| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | FOXO3 DDX17 ARID3A RBL2 POU2F1 NUP62 MLLT10 ARID1A ADNP CLOCK ATF2 PHC1 PHC2 MSL2 PHC3 KAT2B ARID1B SALL1 L3MBTL1 BRD2 GLI3 TOX3 KMT2A ANKRD17 HCFC1 | 4.47e-09 | 739 | 171 | 25 | GO:0003682 |
| GeneOntologyMolecularFunction | histone binding | MLLT10 PHC1 PHC2 PHC3 L3MBTL1 BRD2 SETD5 KMT2A SPTY2D1 TP53BP1 | 9.92e-05 | 265 | 171 | 10 | GO:0042393 |
| GeneOntologyCellularComponent | Golgi lumen | 3.80e-06 | 109 | 175 | 8 | GO:0005796 | |
| GeneOntologyCellularComponent | chromatin | FOXO3 ARID4B MLX BAZ2B RBL2 POU2F1 SIX4 RFX7 ARID1A ADNP RFX3 CLOCK ATF2 CASZ1 PHC1 PHC2 MSL2 KAT2B ARID1B SALL1 L3MBTL1 BRD2 SETD5 ANKRD17 ZFHX3 SPRTN HCFC1 TBX5 NPAS2 | 1.52e-05 | 1480 | 175 | 29 | GO:0000785 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 4.67e-05 | 9 | 175 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | FOXO3 ARID4B MLX HIPK2 POU2F1 NUP62 NUP58 ARID1A ADNP CLOCK ATF2 PRPF40A SF1 PHC1 PHC2 PHC3 ARID1B SALL1 L3MBTL1 SETD5 UBAP2L DOCK7 KMT2A FIP1L1 HCFC1 NPAS2 | 8.20e-05 | 1377 | 175 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | transcription regulator complex | FOXO3 MLX RBL2 HIPK2 POU2F1 SIX4 ADNP RFX3 CLOCK ATF2 SALL1 GLI3 ZFHX3 TBX5 NPAS2 | 1.54e-04 | 596 | 175 | 15 | GO:0005667 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.96e-04 | 14 | 175 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | nuclear body | DDX17 RBM10 OBSCN ANKS1B HIPK2 ERBIN PRPF40A SF1 PHC1 BRD2 MTOR GLI3 NUFIP2 CHEK2 MKI67 ZFHX3 SPRTN HECTD1 TP53BP1 | 2.11e-04 | 903 | 175 | 19 | GO:0016604 |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 4.14e-04 | 4 | 175 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | PRC1 complex | 5.06e-04 | 19 | 175 | 3 | GO:0035102 | |
| GeneOntologyCellularComponent | CLOCK-BMAL transcription complex | 6.85e-04 | 5 | 175 | 2 | GO:1990513 | |
| GeneOntologyCellularComponent | PcG protein complex | 9.39e-04 | 52 | 175 | 4 | GO:0031519 | |
| GeneOntologyCellularComponent | A band | 9.39e-04 | 52 | 175 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | postsynaptic specialization | CACNA1C ARHGAP32 SYN3 ZDHHC5 ANKS1B LRRC4B LRRC4C ERBIN CHRM4 ITPR1 NETO2 MAPK8IP2 | 1.12e-03 | 503 | 175 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | myosin filament | 1.16e-03 | 25 | 175 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1C FZD3 PODXL LRRC4B NBEA LRRC4C MAGEE1 GABBR2 CHRM4 ITPR1 PTPRA KCNQ5 NETO2 | 1.29e-03 | 583 | 175 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | glutamatergic synapse | PRUNE2 CACNA1C SYN3 FZD3 PODXL ZDHHC5 ANKS1B LRRC4B NBEA LRRC4C GABBR2 ERBIN CHRM4 NETO2 MTOR MARK2 | 1.44e-03 | 817 | 175 | 16 | GO:0098978 |
| HumanPheno | Thin upper lip vermilion | CACNA1C ABCC9 RFX7 ARID1A ADNP PHC1 ARID1B PIEZO2 SETD5 UBAP2L MTOR STRADA KMT2A ANKRD17 CEP295 | 1.06e-05 | 339 | 63 | 15 | HP:0000219 |
| HumanPheno | Thin lips | CACNA1C ABCC9 RFX7 ARID1A ADNP PHC1 ARID1B PIEZO2 SETD5 UBAP2L MTOR STRADA KMT2A ANKRD17 CEP295 | 1.06e-05 | 339 | 63 | 15 | HP:0000213 |
| HumanPheno | 3-4 finger cutaneous syndactyly | 4.48e-05 | 17 | 63 | 4 | HP:0011939 | |
| MousePheno | abnormal forebrain morphology | FOXO3 CACNA1C FZD3 ZDHHC5 HIPK2 AMBRA1 GPRIN3 LRRC4B NBEA GABBR2 ARID1A CLOCK ARID1B CCDC88A PTPRA SALL1 BRD2 SETD5 MTOR CXCR4 GLI3 TLR3 STON2 MARK2 HCFC1 HYDIN | 1.35e-05 | 1072 | 137 | 26 | MP:0000783 |
| Domain | DUF4599 | 4.05e-08 | 12 | 167 | 5 | PF15371 | |
| Domain | DUF4599 | 4.05e-08 | 12 | 167 | 5 | IPR027970 | |
| Domain | DUF2012 | 2.79e-06 | 4 | 167 | 3 | PF09430 | |
| Domain | DUF2012 | 2.79e-06 | 4 | 167 | 3 | IPR019008 | |
| Domain | Znf_FCS | 6.93e-06 | 5 | 167 | 3 | IPR012313 | |
| Domain | - | 7.79e-06 | 15 | 167 | 4 | 1.10.150.60 | |
| Domain | BRIGHT | 7.79e-06 | 15 | 167 | 4 | SM00501 | |
| Domain | ARID_dom | 7.79e-06 | 15 | 167 | 4 | IPR001606 | |
| Domain | ARID | 7.79e-06 | 15 | 167 | 4 | PS51011 | |
| Domain | ARID | 7.79e-06 | 15 | 167 | 4 | PF01388 | |
| Domain | ZF_FCS | 1.38e-05 | 6 | 167 | 3 | PS51024 | |
| Domain | Carb-bd-like_fold | 3.80e-05 | 8 | 167 | 3 | IPR013784 | |
| Domain | BAF250/Osa | 7.95e-05 | 2 | 167 | 2 | IPR021906 | |
| Domain | BAF250_C | 7.95e-05 | 2 | 167 | 2 | IPR033388 | |
| Domain | BAF250_C | 7.95e-05 | 2 | 167 | 2 | PF12031 | |
| Domain | CarboxyPept_regulatory_dom | 1.88e-04 | 13 | 167 | 3 | IPR014766 | |
| Domain | - | 1.88e-04 | 13 | 167 | 3 | 2.60.40.1120 | |
| Domain | SAM_1 | 3.56e-04 | 68 | 167 | 5 | PF00536 | |
| Domain | CarboxyPept-like_regulatory | 4.35e-04 | 17 | 167 | 3 | IPR008969 | |
| Domain | PPR | 4.71e-04 | 4 | 167 | 2 | PF01535 | |
| Domain | BROMODOMAIN_2 | 4.82e-04 | 41 | 167 | 4 | PS50014 | |
| Domain | Bromodomain | 5.30e-04 | 42 | 167 | 4 | IPR001487 | |
| Domain | BROMO | 5.30e-04 | 42 | 167 | 4 | SM00297 | |
| Domain | - | 5.30e-04 | 42 | 167 | 4 | 1.20.920.10 | |
| Domain | ARM-type_fold | UBQLN2 DOCK11 RICTOR NBEA HEATR5A FRYL ARID1A ITPR1 MTOR HECTD1 | 9.72e-04 | 339 | 167 | 10 | IPR016024 |
| Domain | SAM | 1.16e-03 | 88 | 167 | 5 | SM00454 | |
| Domain | Haem_d1 | 1.16e-03 | 6 | 167 | 2 | IPR011048 | |
| Domain | DUF3398 | 1.16e-03 | 6 | 167 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 1.16e-03 | 6 | 167 | 2 | IPR021816 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.81e-07 | 16 | 122 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.55e-07 | 17 | 122 | 5 | M27412 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 6.93e-07 | 37 | 122 | 6 | M27797 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 8.14e-07 | 21 | 122 | 5 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.33e-06 | 23 | 122 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.54e-06 | 26 | 122 | 5 | M27483 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.02e-05 | 34 | 122 | 5 | MM15531 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.02e-05 | 65 | 122 | 6 | M39682 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.31e-05 | 40 | 122 | 5 | MM15000 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.71e-05 | 44 | 122 | 5 | M27295 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.13e-05 | 47 | 122 | 5 | M27395 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 6.89e-05 | 26 | 122 | 4 | M47923 | |
| Pathway | REACTOME_SUMOYLATION | 1.09e-04 | 169 | 122 | 8 | MM14919 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.42e-04 | 58 | 122 | 5 | MM15149 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.67e-04 | 60 | 122 | 5 | MM15636 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | FOXO3 HIPK2 POU2F1 RICTOR NUP62 NUP58 ARID1A PHC1 PHC2 PHC3 KAT2B L3MBTL1 MTOR CTDP1 CHEK2 KMT2A FIP1L1 ZFHX3 RPRD2 HCFC1 TBX5 | 1.70e-04 | 1022 | 122 | 21 | MM15436 |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 1.81e-04 | 61 | 122 | 5 | M27811 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.95e-04 | 62 | 122 | 5 | M546 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.12e-04 | 140 | 122 | 7 | M27484 | |
| Pathway | REACTOME_PHYSIOLOGICAL_FACTORS | 2.15e-04 | 14 | 122 | 3 | M27459 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 2.27e-04 | 35 | 122 | 4 | M249 | |
| Pathway | REACTOME_SUMOYLATION | 2.36e-04 | 189 | 122 | 8 | M27214 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.44e-04 | 65 | 122 | 5 | MM15147 | |
| Pathway | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | 2.67e-04 | 15 | 122 | 3 | M603 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 2.67e-04 | 15 | 122 | 3 | M48306 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.02e-04 | 68 | 122 | 5 | M27303 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS | 3.26e-04 | 16 | 122 | 3 | M27403 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.65e-04 | 153 | 122 | 7 | MM15522 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.69e-04 | 71 | 122 | 5 | M27394 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 3.82e-04 | 110 | 122 | 6 | M48043 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.37e-04 | 77 | 122 | 5 | M27226 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.93e-04 | 272 | 122 | 9 | M29619 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 7.14e-04 | 47 | 122 | 4 | M39518 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | FOXO3 ARID3A RBL2 HIPK2 POU2F1 RICTOR ARID1A ATF2 PHC1 PHC2 PHC3 KAT2B ARID1B L3MBTL1 BRD2 MTOR GLI3 CTDP1 CHEK2 KMT2A FIP1L1 ZFHX3 RPRD2 TBX5 | 7.21e-04 | 1387 | 122 | 24 | M734 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 8.00e-04 | 84 | 122 | 5 | MM14929 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 9.25e-04 | 130 | 122 | 6 | M27454 | |
| Pathway | WP_TCELL_ACTIVATION_SARSCOV2 | 9.88e-04 | 88 | 122 | 5 | M42580 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 1.05e-03 | 52 | 122 | 4 | M7561 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.05e-03 | 237 | 122 | 8 | M27786 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.09e-03 | 6 | 122 | 2 | MM15660 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.21e-03 | 301 | 122 | 9 | MM15983 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 RAF1 NES ARHGAP32 DENND4A DOCK11 SIPA1L3 RICTOR FAM117B FSD1 FRYL NUP62 INPP5F RFX7 PRAG1 ERBIN DENND4C CCDC88A KCNQ5 MTOR DOCK7 NAV2 KMT2A FIP1L1 ANKRD17 MARK2 HECTD1 SH3RF3 TMCC1 ARHGAP21 | 8.17e-17 | 861 | 176 | 30 | 36931259 |
| Pubmed | FLG ARHGAP32 ARID3A ARID4B RBM10 HIPK2 POU2F1 PROSER1 NUP62 SIX4 MLLT10 RFX7 ARID1A ADNP ERBIN PRPF40A EMSY PHC3 KAT2B ARID1B SALL1 BRD2 UBAP2L GLI3 MKI67 KMT2A FIP1L1 ANKRD17 ZFHX3 RPRD2 QSER1 HERC1 HCFC1 TP53BP1 | 4.42e-14 | 1429 | 176 | 34 | 35140242 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | ARID3A BAZ2B CDKN2AIP PROSER1 NUP62 NUP58 ARID1A ADNP PRPF40A PHC1 PHC2 MSL2 SALL1 BRD2 KMT2A SPTY2D1 HCFC1 TBX5 | 4.24e-12 | 411 | 176 | 18 | 35182466 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | DOCK11 RBM10 AMBRA1 RICTOR NUP62 ZFC3H1 ARID1A ADNP ITPR1 ARID1B UBAP2L NUFIP2 MKI67 FIP1L1 ANKRD17 RPRD2 HECTD1 TP53BP1 | 1.31e-11 | 440 | 176 | 18 | 34244565 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 ABCA2 REPS1 ARID3A RHBDF2 SIPA1L3 OBSCN ZDHHC5 AMBRA1 FRYL MLLT10 ARID1A PRAG1 BIRC6 CHRM4 CASZ1 PHC2 BRD2 SETD5 MTOR CTDP1 NAV2 HERC1 HECTD1 ULK2 HCFC1 ARHGAP21 | 1.37e-11 | 1105 | 176 | 27 | 35748872 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DDX17 ARID4B MLX BAZ2B RBM10 NUP62 ZFC3H1 SIX4 RFX7 ARID1A ADNP CLOCK ATF2 PRPF40A SF1 CASZ1 EMSY PHC2 MSL2 PHC3 BRD2 USP42 MKI67 KMT2A FIP1L1 RPRD2 QSER1 SPTY2D1 HCFC1 | 1.76e-11 | 1294 | 176 | 29 | 30804502 |
| Pubmed | Interaction network of human early embryonic transcription factors. | ARID3A ARID4B POU2F1 PROSER1 NUP58 SIX4 RFX7 ARID1A EMSY KAT2B ARID1B SALL1 MKI67 KMT2A ZFHX3 QSER1 | 3.84e-11 | 351 | 176 | 16 | 38297188 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ARID4B RBM10 POU2F1 RICTOR RFX7 ERBIN ATF2 PRPF40A SF1 EMSY PHC2 PHC3 BRD2 USP42 UBAP2L CTDP1 MKI67 KMT2A FIP1L1 ANKRD17 MARK2 TP53BP1 | 7.49e-11 | 774 | 176 | 22 | 15302935 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DDX17 ARID4B BAZ2B RBM10 CDKN2AIP NUP62 ARID1A ADNP PRPF40A SF1 EMSY PHC3 ARID1B SALL1 BRD2 UBAP2L NUFIP2 MKI67 KMT2A FIP1L1 RPRD2 QSER1 HCFC1 TP53BP1 | 1.16e-10 | 954 | 176 | 24 | 36373674 |
| Pubmed | FOXO3 RAF1 DENND4A DOCK11 SIPA1L3 RICTOR FRYL INPP5F ARID1A BIRC6 DENND4C ARID1B DOCK7 CEP295 MARK2 HECTD1 SH3RF3 | 1.48e-10 | 446 | 176 | 17 | 24255178 | |
| Pubmed | FOXO3 ARID3A MLX RBM10 ZDHHC5 POU2F1 SIX4 MLLT10 ARID1A RFX3 CLOCK ATF2 SF1 PHC1 KAT2B SALL1 BRD2 GLI3 TOX3 ZFHX3 TBX5 NPAS2 | 1.69e-10 | 808 | 176 | 22 | 20412781 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | WHRN FOXO3 RAF1 FLG DENND4A DDX17 ARID3A AMBRA1 PCARE FAM117B RFX3 CLOCK DENND4C NOMO1 CCDC88A SETD5 MTOR CXCR4 GLI3 RTL9 NUFIP2 DOCK7 EXOC1 QSER1 MARK2 SH3RF3 TP53BP1 | 7.15e-10 | 1321 | 176 | 27 | 27173435 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | RBM10 ARID1A ADNP ERBIN SF1 EMSY ARID1B NUFIP2 MKI67 KMT2A FIP1L1 GREB1 HCFC1 TP53BP1 | 2.57e-09 | 341 | 176 | 14 | 32971831 |
| Pubmed | NES ARHGAP32 DOCK11 SIPA1L3 ANKS1B TRIOBP NBEA GABBR2 ADNP ERBIN EMSY CCDC88A UBAP2L MTOR NUFIP2 STON2 DOCK7 ANKRD17 QSER1 ARHGAP21 MAPK8IP2 TP53BP1 | 4.30e-09 | 963 | 176 | 22 | 28671696 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CACNA1C DOCK11 CDKN2AIP OBSCN NBEA SPATA31A6 NAV2 KMT2A MYOM2 MARK2 HERC1 MUC4 SH3RF3 HCFC1 ARHGAP21 HYDIN | 5.88e-09 | 497 | 176 | 16 | 36774506 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 PRUNE2 CACNA1C RHBDF2 STXBP5L SIPA1L3 OBSCN HIPK2 TRIOBP FAM117B FRYL ARID1A ERBIN CASZ1 KCNQ5 SETD5 UBAP2L TOX3 ANKRD17 ZFHX3 RPRD2 GREB1 QSER1 HECTD1 SH3RF3 TMCC1 NPAS2 | 9.12e-09 | 1489 | 176 | 27 | 28611215 |
| Pubmed | 9.43e-09 | 6 | 176 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 9.43e-09 | 6 | 176 | 4 | 25930072 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | DDX17 REPS1 DSG1 RBM10 CDKN2AIP NUP62 ADNP ERBIN PRPF40A SF1 EMSY PHC3 UBAP2L NUFIP2 MKI67 KMT2A ANKRD17 RPRD2 HCFC1 ARHGAP21 TP53BP1 | 1.31e-08 | 934 | 176 | 21 | 33916271 |
| Pubmed | ARHGAP32 DDX17 SYN3 DSG1 STXBP5L ANKS1B TRIOBP RICTOR LRRC4B NBEA LRRC4C GABBR2 BIRC6 ERBIN ITPR1 CCDC88A KCNQ5 UBAP2L NUFIP2 DOCK7 EXOC1 TMCC1 TP53BP1 | 1.85e-08 | 1139 | 176 | 23 | 36417873 | |
| Pubmed | REPS1 RBM10 ARID1A ADNP ERBIN PRPF40A EMSY ARID1B UBAP2L NUFIP2 DOCK7 KMT2A RPRD2 QSER1 HCFC1 TP53BP1 | 2.36e-08 | 549 | 176 | 16 | 38280479 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.55e-08 | 18 | 176 | 5 | 18834073 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 3.01e-08 | 134 | 176 | 9 | 25452129 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | ARHGAP32 RBM10 ZDHHC5 NUP58 RFX7 ERBIN SF1 FIP1L1 RPRD2 MARK2 | 3.10e-08 | 180 | 176 | 10 | 35198878 |
| Pubmed | WHRN RBM10 MAGEE1 CASZ1 KCNQ5 UBAP2L GLI3 MKI67 CEP295 EXOC1 MAPK8IP2 | 3.34e-08 | 233 | 176 | 11 | 37704626 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RAF1 ARHGAP32 RHBDF2 PODXL ZDHHC5 RICTOR ERBIN JPH1 PIEZO2 PTPRA MTOR STON2 DOCK7 NAV2 MARK2 ARHGAP21 | 3.86e-08 | 569 | 176 | 16 | 30639242 |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 5.36e-08 | 102 | 176 | 8 | 15778465 | |
| Pubmed | ARHGAP32 RBM10 ZDHHC5 ARID1A ERBIN CCDC88A GLI3 NUFIP2 MKI67 FIP1L1 ARHGAP21 | 1.14e-07 | 263 | 176 | 11 | 34702444 | |
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 30236127 | ||
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.27e-07 | 3 | 176 | 3 | 25576386 | |
| Pubmed | 1.30e-07 | 10 | 176 | 4 | 15922553 | ||
| Pubmed | ARHGAP32 DDX17 REPS1 ZDHHC5 RICTOR ERBIN PRPF40A DENND4C JPH1 CCDC88A UBAP2L NUFIP2 DOCK7 ANKRD17 MARK2 HCFC1 ARHGAP21 | 1.37e-07 | 708 | 176 | 17 | 39231216 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | DDX17 RBM10 HIPK2 ARID1A ADNP PRPF40A CASZ1 ARID1B ZFHX3 HCFC1 | 2.03e-07 | 220 | 176 | 10 | 35785414 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.30e-07 | 123 | 176 | 8 | 26912792 | |
| Pubmed | RAF1 INPP5F ADNP BIRC6 DENND4C PHC1 PHC3 CCDC88A SALL1 DOCK7 ANKRD17 ZFHX3 ARHGAP21 | 2.45e-07 | 418 | 176 | 13 | 34709266 | |
| Pubmed | NES FRYL ARID1A ADNP BIRC6 PRPF40A UBAP2L MTOR NUFIP2 MKI67 DOCK7 KMT2A ANKRD17 HECTD1 HCFC1 TP53BP1 | 2.49e-07 | 653 | 176 | 16 | 22586326 | |
| Pubmed | PRUNE2 ARHGAP32 BAZ2B SIPA1L3 ZDHHC5 GPRIN3 RICTOR ZFC3H1 USP37 BIRC6 CASZ1 MSL2 HECTD1 TMCC1 | 2.51e-07 | 493 | 176 | 14 | 15368895 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXO3 ARID3A ARID4B RBL2 POU2F1 SIX4 ADNP RFX3 ATF2 CASZ1 EMSY SALL1 CHEK2 FIP1L1 ANKRD17 QSER1 HCFC1 TP53BP1 | 4.12e-07 | 857 | 176 | 18 | 25609649 |
| Pubmed | ARHGAP32 CDKN2AIP SIPA1L3 ZDHHC5 TRIOBP GPRIN3 RICTOR NBEA SIX4 ARID1A BIRC6 ERBIN ITPR1 ARID1B CCDC88A PTPRA BRD2 NUFIP2 MKI67 HERC1 | 4.16e-07 | 1049 | 176 | 20 | 27880917 | |
| Pubmed | DDX17 PODXL ZDHHC5 MUC16 GPRIN3 RICTOR NBEA BIRC6 ERBIN CCDC88A GLI3 MKI67 DOCK7 FIP1L1 ZFHX3 SPTY2D1 ARHGAP21 | 5.02e-07 | 777 | 176 | 17 | 35844135 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 5.08e-07 | 4 | 176 | 3 | 31833031 | |
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 9267806 | ||
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 10438587 | ||
| Pubmed | REPS1 CDKN2AIP SIPA1L3 TRIOBP RICTOR NUP62 ZFC3H1 SIX4 ERBIN CASZ1 EMSY PHC2 NOMO1 MSL2 PHC3 BRD2 SETD5 NUFIP2 KMT2A ANKRD17 ZFHX3 MARK2 SPTY2D1 TMCC1 | 6.19e-07 | 1497 | 176 | 24 | 31527615 | |
| Pubmed | ABCA2 UBQLN2 REPS1 RBL2 SIPA1L3 ANKS1B TRIOBP NBEA NUP58 ZFC3H1 ARID1A SF1 JPH1 CLIP4 PTPRA BRD2 NOMO2 FIP1L1 EXOC1 HECTD1 ARHGAP21 MAPK8IP2 | 6.47e-07 | 1285 | 176 | 22 | 35914814 | |
| Pubmed | 1.23e-06 | 268 | 176 | 10 | 33640491 | ||
| Pubmed | STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. | 1.26e-06 | 5 | 176 | 3 | 20424326 | |
| Pubmed | 1.26e-06 | 5 | 176 | 3 | 19703998 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.28e-06 | 154 | 176 | 8 | 16055720 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 1.42e-06 | 69 | 176 | 6 | 28481362 | |
| Pubmed | Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. | 1.43e-06 | 17 | 176 | 4 | 17322895 | |
| Pubmed | DENND4A REPS1 MYOM1 MLX OBSCN BIRC6 SF1 JPH1 CLIP4 ARID1B EXOC1 MYOM2 ARHGAP21 | 1.70e-06 | 497 | 176 | 13 | 23414517 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NES CDSN DDX17 DSG1 PODXL FRYL NUP62 ARID1A ADNP ERBIN PRPF40A SF1 EMSY IGLV3-21 UBAP2L MTOR ANKRD17 EXOC1 NGLY1 MUC7 HCFC1 TP53BP1 | 1.79e-06 | 1367 | 176 | 22 | 32687490 |
| Pubmed | DDX17 SF1 DENND4C UBAP2L NUFIP2 CTDP1 MKI67 NAV2 FIP1L1 RPRD2 MARK2 HCFC1 TP53BP1 | 1.94e-06 | 503 | 176 | 13 | 16964243 | |
| Pubmed | 2.16e-06 | 222 | 176 | 9 | 37071664 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 RAF1 ARHGAP32 UBQLN2 FSD1 MLLT10 MAGEE1 ADNP PHC3 SALL1 STON2 SPRTN | 2.22e-06 | 430 | 176 | 12 | 35044719 |
| Pubmed | Nestin expression is dynamically regulated in cardiomyocytes during embryogenesis. | 2.52e-06 | 6 | 176 | 3 | 28834610 | |
| Pubmed | Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors. | 2.52e-06 | 6 | 176 | 3 | 25418727 | |
| Pubmed | FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage. | 2.52e-06 | 6 | 176 | 3 | 22893124 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | DDX17 TRIOBP ZFC3H1 PRAG1 ERBIN PRPF40A EMSY MKI67 FIP1L1 RPRD2 ARHGAP21 | 2.58e-06 | 361 | 176 | 11 | 30344098 |
| Pubmed | OBSCN HIPK2 RICTOR FRYL ERBIN ATF2 ITPR1 PHC3 ARID1B SETD5 UBAP2L ANKRD17 CEP295 QSER1 HERC1 ULK2 SPTY2D1 ARHGAP21 TP53BP1 | 2.83e-06 | 1084 | 176 | 19 | 11544199 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ARID3A ARID4B BAZ2B POU2F1 ADNP CASZ1 EMSY PHC1 PHC3 BRD2 MKI67 KMT2A QSER1 HCFC1 | 2.96e-06 | 608 | 176 | 14 | 36089195 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | CDSN REPS1 ARID3A CDKN2AIP ADNP PRPF40A SF1 EMSY SALL1 UBAP2L NUFIP2 HCFC1 | 3.09e-06 | 444 | 176 | 12 | 34795231 |
| Pubmed | RAF1 NES ARHGAP32 DDX17 SYN3 SIPA1L3 ANKS1B NBEA ARID1A ERBIN PRPF40A PTPRA UBAP2L NUFIP2 STON2 DOCK7 KMT2A EXOC1 HADH MARK2 ARHGAP21 MAPK8IP2 | 3.73e-06 | 1431 | 176 | 22 | 37142655 | |
| Pubmed | NES ABCA2 MLX FZD3 FRYL ERBIN ATF2 CASZ1 PHC1 PHC2 NOMO1 BRD2 NOMO2 KMT2A GREB1 HADH NOMO3 NPAS2 | 3.95e-06 | 1006 | 176 | 18 | 15226823 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXO3 MLX POU2F1 SIX4 RFX7 FOXI3 ADNP RFX3 CLOCK ATF2 SALL1 GLI3 TOX3 KMT2A ZFHX3 TBX5 NPAS2 | 4.11e-06 | 908 | 176 | 17 | 19274049 |
| Pubmed | 4.21e-06 | 83 | 176 | 6 | 28794006 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | RAF1 REPS1 RBL2 HIPK2 ADNP PRAG1 NOMO1 BRD2 NOMO2 STRADA NUFIP2 STON2 CHEK2 KMT2A MARK2 ARHGAP21 NOMO3 | 4.23e-06 | 910 | 176 | 17 | 36736316 |
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 17141160 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 4.72e-06 | 130 | 176 | 7 | 35545047 | |
| Pubmed | Sonic hedgehog acts cell-autonomously on muscle precursor cells to generate limb muscle diversity. | 5.21e-06 | 23 | 176 | 4 | 22987640 | |
| Pubmed | NES BIRC6 ERBIN DENND4C JPH1 ARID1B CCDC88A NOMO2 NUFIP2 FIP1L1 RPRD2 CEP295 QSER1 HECTD1 HCFC1 | 5.43e-06 | 733 | 176 | 15 | 34672954 | |
| Pubmed | 6.22e-06 | 24 | 176 | 4 | 32212159 | ||
| Pubmed | 6.66e-06 | 255 | 176 | 9 | 15324660 | ||
| Pubmed | RBM10 PRPF40A SF1 BRD2 UBAP2L NUFIP2 MKI67 RPRD2 QSER1 HCFC1 TP53BP1 | 6.67e-06 | 399 | 176 | 11 | 35987950 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | DSG1 CDKN2AIP PRPF40A SF1 MTOR MKI67 DOCK7 FIP1L1 MARK2 HECTD1 TP53BP1 | 6.82e-06 | 400 | 176 | 11 | 35013556 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 6.87e-06 | 256 | 176 | 9 | 33397691 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 7.00e-06 | 8 | 176 | 3 | 15257293 | |
| Pubmed | FBXL5 Inactivation in Mouse Brain Induces Aberrant Proliferation of Neural Stem Progenitor Cells. | 7.38e-06 | 25 | 176 | 4 | 28069738 | |
| Pubmed | NES DDX17 RBM10 SIPA1L3 ZDHHC5 NUP62 NUP58 ERBIN PRPF40A SF1 BRD2 NUFIP2 MKI67 DOCK7 | 7.54e-06 | 660 | 176 | 14 | 32780723 | |
| Pubmed | WHRN RBM10 HEATR5A LRRC4C ERBIN SETD5 UBAP2L NUFIP2 DOCK7 ULK2 ARHGAP21 | 8.03e-06 | 407 | 176 | 11 | 12693553 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 9.52e-06 | 202 | 176 | 8 | 33005030 | |
| Pubmed | 9.85e-06 | 339 | 176 | 10 | 30415952 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 37805104 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.05e-05 | 9 | 176 | 3 | 36261522 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG NES CDSN DDX17 RBM10 TRIOBP ARID1A ADNP PRPF40A SF1 PHC2 ARID1B BRD2 USP42 CFAP45 DOCK7 FIP1L1 NPAS2 | 1.06e-05 | 1082 | 176 | 18 | 38697112 |
| Pubmed | ARHGAP32 ZDHHC5 TRIOBP GPRIN3 RICTOR ERBIN NOMO1 JPH1 CCDC88A MARK2 ARHGAP21 | 1.10e-05 | 421 | 176 | 11 | 36976175 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | DDX17 BIRC6 NOMO1 NOMO2 UBAP2L HADH HECTD1 HCFC1 NOMO3 TP53BP1 | 1.12e-05 | 344 | 176 | 10 | 30333137 |
| Pubmed | FLG SWT1 BAZ2B STXBP5L RBL2 POU2F1 NUP58 C2orf78 CLOCK ERBIN DENND4C LRRD1 HYDIN NPAS2 | 1.16e-05 | 686 | 176 | 14 | 29987050 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.21e-05 | 150 | 176 | 7 | 28242625 | |
| Pubmed | 1.22e-05 | 209 | 176 | 8 | 36779422 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NES DDX17 DSG1 RBM10 ADNP ERBIN PRPF40A SF1 PHC2 BRD2 USP42 NUFIP2 MKI67 FIP1L1 SPTY2D1 HCFC1 TP53BP1 | 1.25e-05 | 989 | 176 | 17 | 36424410 |
| Pubmed | 1.31e-05 | 101 | 176 | 6 | 10997877 | ||
| Pubmed | Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy. | 1.36e-05 | 29 | 176 | 4 | 26633882 | |
| Pubmed | 1.36e-05 | 29 | 176 | 4 | 36800290 | ||
| Pubmed | DDX17 ARID3A BAZ2B RBM10 CDKN2AIP POU2F1 ARID1A ADNP ATF2 SF1 EMSY ARID1B MKI67 KMT2A FIP1L1 QSER1 HCFC1 TP53BP1 | 1.38e-05 | 1103 | 176 | 18 | 34189442 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | FLG DDX17 DSG1 RBM10 ARID1A ADNP PRPF40A BRD2 NUFIP2 MKI67 KMT2A FIP1L1 ZFHX3 | 1.41e-05 | 605 | 176 | 13 | 28977666 |
| Pubmed | FOXO3 ARID4B MLX RBL2 CDKN2AIP POU2F1 RICTOR BIRC6 EMSY MSL2 PTPRA SALL1 BRD2 STRADA GLI3 CHEK2 KMT2A ANKRD17 HECTD1 ULK2 | 1.42e-05 | 1327 | 176 | 20 | 32694731 | |
| Pubmed | CACNA1C FLG DENND4A DDX17 SIPA1L3 SKIDA1 ANKS1B NUP62 ZFC3H1 ARID1A C2orf78 ERBIN BRD2 SETD5 CFAP45 NAV2 KMT2A CEP295 MYOM2 NGLY1 ARHGAP21 | 1.42e-05 | 1442 | 176 | 21 | 35575683 | |
| Interaction | YWHAG interactions | FOXO3 RAF1 ARHGAP32 DENND4A DDX17 MLX DOCK11 SIPA1L3 RICTOR FAM117B FRYL NUP62 INPP5F USP37 RFX7 PRAG1 ERBIN ATF2 PRPF40A DENND4C MSL2 CCDC88A KCNQ5 MTOR NUFIP2 DOCK7 NAV2 KMT2A FIP1L1 ANKRD17 MARK2 HECTD1 SH3RF3 TMCC1 ARHGAP21 | 2.95e-10 | 1248 | 171 | 35 | int:YWHAG |
| Interaction | YWHAH interactions | FOXO3 RAF1 NES ARHGAP32 DENND4A ABCA2 RHBDF2 DOCK11 SIPA1L3 RICTOR FAM117B FSD1 FRYL NUP62 INPP5F RFX7 PRAG1 ERBIN DENND4C CCDC88A KCNQ5 MTOR DOCK7 NAV2 KMT2A ANKRD17 MARK2 HERC1 HECTD1 SH3RF3 TMCC1 ARHGAP21 | 8.34e-10 | 1102 | 171 | 32 | int:YWHAH |
| Interaction | SFN interactions | FOXO3 RAF1 ARHGAP32 DENND4A DOCK11 SIPA1L3 RICTOR FAM117B FRYL INPP5F ERBIN ATF2 DENND4C CCDC88A KCNQ5 MTOR DOCK7 NAV2 KMT2A ANKRD17 MARK2 HECTD1 TMCC1 ARHGAP21 | 4.87e-09 | 692 | 171 | 24 | int:SFN |
| Interaction | FEV interactions | ARID3A ARID4B POU2F1 SIX4 MLLT10 ARID1A EMSY PHC3 ARID1B SALL1 KMT2A ZFHX3 QSER1 | 2.00e-08 | 203 | 171 | 13 | int:FEV |
| Interaction | EGR2 interactions | ARID3A ARID4B PROSER1 SIX4 ARID1A EMSY KAT2B ARID1B KMT2A ZFHX3 QSER1 HCFC1 | 2.59e-08 | 171 | 171 | 12 | int:EGR2 |
| Interaction | CSNK2A2 interactions | RAF1 ARID4B MLX RBL2 RBM10 ZFC3H1 ADNP ATF2 PRPF40A SF1 EMSY PHC1 PHC2 PHC3 BRD2 GLI3 CTDP1 CHEK2 MKI67 DOCK7 KMT2A FIP1L1 TP53BP1 | 4.53e-08 | 718 | 171 | 23 | int:CSNK2A2 |
| Interaction | YWHAB interactions | FOXO3 RAF1 ARHGAP32 DENND4A MLX DOCK11 SIPA1L3 RICTOR FAM117B FRYL INPP5F RFX7 ERBIN ATF2 DENND4C CCDC88A KCNQ5 MTOR DOCK7 NAV2 KMT2A ANKRD17 MARK2 HECTD1 SH3RF3 TMCC1 ARHGAP21 | 1.23e-07 | 1014 | 171 | 27 | int:YWHAB |
| Interaction | YWHAE interactions | FOXO3 RAF1 ARHGAP32 DENND4A SYN3 MLX DOCK11 RBM10 SIPA1L3 RICTOR FAM117B FRYL INPP5F PRAG1 ERBIN DENND4C MSL2 CCDC88A KCNQ5 MTOR DOCK7 NAV2 KMT2A ANKRD17 MARK2 SPRTN HECTD1 SH3RF3 TMCC1 ARHGAP21 | 2.38e-07 | 1256 | 171 | 30 | int:YWHAE |
| Interaction | YY1 interactions | RAF1 ARID4B ADNP ATF2 PRPF40A EMSY MSL2 PHC3 KAT2B BRD2 MTOR NUFIP2 MKI67 KMT2A FIP1L1 SPRTN HCFC1 | 3.45e-07 | 454 | 171 | 17 | int:YY1 |
| Interaction | NUP43 interactions | DDX17 ARID4B DSG1 BAZ2B CDKN2AIP MUC19 RICTOR NUP62 ZFC3H1 ARID1A EMSY MSL2 PHC3 ARID1B CCDC88A TOX3 MKI67 KMT2A ZFHX3 HCFC1 | 3.74e-07 | 625 | 171 | 20 | int:NUP43 |
| Interaction | NFIX interactions | ARID3A ARID4B POU2F1 SIX4 ARID1A EMSY ARID1B SALL1 BRD2 KMT2A ZFHX3 QSER1 | 5.68e-07 | 227 | 171 | 12 | int:NFIX |
| Interaction | TBX5 interactions | 6.26e-07 | 150 | 171 | 10 | int:TBX5 | |
| Interaction | YWHAZ interactions | FOXO3 RAF1 ARHGAP32 CDSN DENND4A MLX DOCK11 SIPA1L3 RICTOR FAM117B FRYL INPP5F ARID1A ERBIN DENND4C ITPR1 MSL2 CCDC88A PTPRA KCNQ5 MTOR DOCK7 NAV2 KMT2A ANKRD17 MARK2 HECTD1 TMCC1 ARHGAP21 TP53BP1 | 6.70e-07 | 1319 | 171 | 30 | int:YWHAZ |
| Interaction | FBXO22 interactions | CACNA1C DOCK11 CDKN2AIP OBSCN NBEA SPATA31A6 CHEK2 NAV2 KMT2A MYOM2 MARK2 HERC1 MUC4 SH3RF3 HCFC1 ARHGAP21 HYDIN TP53BP1 | 8.33e-07 | 540 | 171 | 18 | int:FBXO22 |
| Interaction | KRT8 interactions | RAF1 NES DENND4A SIPA1L3 ZDHHC5 POU2F1 RICTOR NUP62 C2orf78 BIRC6 ATF2 PHC3 CFAP45 DOCK7 HECTD1 ARHGAP21 | 1.18e-06 | 441 | 171 | 16 | int:KRT8 |
| Interaction | RHOF interactions | ARHGAP32 DOCK11 PODXL SIPA1L3 ZDHHC5 TRIOBP RICTOR HEATR5A ERBIN DENND4C JPH1 CCM2 CCDC88A MTOR CXCR4 STON2 DOCK7 QSER1 MARK2 ARHGAP21 | 1.19e-06 | 673 | 171 | 20 | int:RHOF |
| Interaction | HDAC2 interactions | RAF1 DDX17 USP17L2 ARID4B PODXL CDKN2AIP USP37 ARID1A RFX3 SF1 CASZ1 EMSY DENND4C PHC1 PHC2 KAT2B SALL1 NUFIP2 MKI67 KMT2A ANKRD17 RPRD2 HCFC1 | 1.20e-06 | 865 | 171 | 23 | int:HDAC2 |
| Interaction | SMC5 interactions | DDX17 ARID4B BAZ2B RBM10 CDKN2AIP NUP62 ARID1A ADNP PRPF40A SF1 EMSY PHC3 ARID1B SALL1 BRD2 UBAP2L NUFIP2 MKI67 KMT2A FIP1L1 RPRD2 QSER1 HECTD1 HCFC1 TP53BP1 | 1.21e-06 | 1000 | 171 | 25 | int:SMC5 |
| Interaction | SIRT6 interactions | FOXO3 DOCK11 RBM10 AMBRA1 RICTOR NUP62 ZFC3H1 ARID1A ADNP ITPR1 ARID1B UBAP2L NUFIP2 MKI67 FIP1L1 ANKRD17 RPRD2 HECTD1 TP53BP1 | 1.72e-06 | 628 | 171 | 19 | int:SIRT6 |
| Interaction | CSNK2A1 interactions | RAF1 FLG DENND4A DDX17 ARID4B MLX RBL2 RBM10 RICTOR ZFC3H1 ADNP BIRC6 ATF2 PRPF40A PHC1 PHC2 KAT2B BRD2 CTDP1 CHEK2 KMT2A FIP1L1 RPRD2 HCFC1 | 1.89e-06 | 956 | 171 | 24 | int:CSNK2A1 |
| Interaction | H2BC21 interactions | ARID4B DSG1 OBSCN HIPK2 MLLT10 ARID1A ADNP ATF2 PHC1 PHC2 MSL2 KAT2B ARID1B BRD2 USP42 MKI67 KMT2A RPRD2 QSER1 HCFC1 | 1.98e-06 | 696 | 171 | 20 | int:H2BC21 |
| Interaction | TOP3B interactions | FOXO3 ABCA2 REPS1 ARID3A RHBDF2 SIPA1L3 OBSCN ZDHHC5 AMBRA1 FRYL MLLT10 ARID1A PRAG1 BIRC6 CHRM4 CASZ1 PHC2 BRD2 SETD5 UBAP2L MTOR NUFIP2 CTDP1 NAV2 ANKRD17 HERC1 HECTD1 ULK2 HCFC1 ARHGAP21 TP53BP1 | 2.10e-06 | 1470 | 171 | 31 | int:TOP3B |
| Interaction | SNRNP40 interactions | RAF1 DDX17 DSG1 BAZ2B RBM10 CDKN2AIP ZFC3H1 USP37 ARID1A PRPF40A EMSY PHC3 ARID1B USP42 MKI67 KMT2A ZFHX3 HECTD1 SPTY2D1 | 2.12e-06 | 637 | 171 | 19 | int:SNRNP40 |
| Interaction | YWHAQ interactions | FOXO3 RAF1 ARHGAP32 CDSN DENND4A DOCK11 SIPA1L3 RICTOR FAM117B FRYL INPP5F RFX7 ERBIN DENND4C CCDC88A KCNQ5 USP42 MTOR DOCK7 NAV2 KMT2A ANKRD17 MARK2 HECTD1 TMCC1 ARHGAP21 | 2.76e-06 | 1118 | 171 | 26 | int:YWHAQ |
| Interaction | HNF1B interactions | ARID3A ARID4B PROSER1 SIX4 MLLT10 ARID1A KAT2B ARID1B ZFHX3 QSER1 | 5.31e-06 | 190 | 171 | 10 | int:HNF1B |
| Interaction | PLK1 interactions | FOXO3 DDX17 UBQLN2 DSG1 TRIOBP RICTOR USP37 RFX3 BIRC6 PHC2 JPH1 MTOR CHEK2 HECTD1 TP53BP1 TBX5 | 7.54e-06 | 510 | 171 | 16 | int:PLK1 |
| Interaction | PHF21A interactions | RAF1 NUP62 NUP58 INPP5F CLOCK BIRC6 DENND4C CCDC88A SALL1 DOCK7 ZFHX3 EXOC1 ARHGAP21 | 7.71e-06 | 343 | 171 | 13 | int:PHF21A |
| Interaction | SLX4 interactions | CDSN DDX17 DSG1 BAZ2B RBM10 ZFC3H1 ADNP EMSY SALL1 BRD2 NUFIP2 MKI67 RPRD2 SPRTN SPTY2D1 HCFC1 TP53BP1 | 7.87e-06 | 572 | 171 | 17 | int:SLX4 |
| Interaction | E2F1 interactions | ARID3A RBL2 EMSY KAT2B ARID1B BRD2 CTDP1 CHEK2 HCFC1 TP53BP1 | 8.35e-06 | 200 | 171 | 10 | int:E2F1 |
| Interaction | ASF1A interactions | ARID1A CASZ1 EMSY ARID1B BRD2 CHEK2 KMT2A FIP1L1 QSER1 SPTY2D1 HCFC1 | 9.53e-06 | 249 | 171 | 11 | int:ASF1A |
| Interaction | SP7 interactions | ARID3A ARID4B RBM10 POU2F1 PROSER1 SIX4 ARID1A PRPF40A KAT2B ARID1B RPRD2 QSER1 | 1.16e-05 | 304 | 171 | 12 | int:SP7 |
| Interaction | C11orf52 interactions | ARHGAP32 SIPA1L3 ZDHHC5 GPRIN3 RICTOR ERBIN JPH1 CCDC88A STON2 DOCK7 MARK2 ARHGAP21 | 1.46e-05 | 311 | 171 | 12 | int:C11orf52 |
| Interaction | WWTR1 interactions | RBM10 ARID1A ADNP CLOCK ERBIN PRPF40A EMSY ARID1B DOCK7 KMT2A RPRD2 QSER1 HCFC1 TP53BP1 | 1.54e-05 | 422 | 171 | 14 | int:WWTR1 |
| Interaction | KCNA3 interactions | RAF1 ARHGAP32 DDX17 REPS1 ZDHHC5 RICTOR ERBIN PRPF40A SF1 DENND4C JPH1 CCDC88A UBAP2L TLR3 NUFIP2 DOCK7 KMT2A ANKRD17 MARK2 HCFC1 ARHGAP21 | 1.62e-05 | 871 | 171 | 21 | int:KCNA3 |
| Interaction | RNF43 interactions | ARHGAP32 DDX17 RBM10 OBSCN ZDHHC5 ARID1A ERBIN CCDC88A USP42 GLI3 NUFIP2 MKI67 FIP1L1 ARHGAP21 | 1.76e-05 | 427 | 171 | 14 | int:RNF43 |
| Interaction | SIRT7 interactions | RAF1 NES USP17L2 FRYL ARID1A ADNP BIRC6 PRPF40A KAT2B UBAP2L MTOR NUFIP2 MKI67 DOCK7 KMT2A ANKRD17 HECTD1 HCFC1 TP53BP1 | 1.92e-05 | 744 | 171 | 19 | int:SIRT7 |
| Interaction | TLE3 interactions | DDX17 BAZ2B PROSER1 SIX4 MLLT10 ARID1A CLOCK EMSY PHC3 ARID1B SALL1 KMT2A ZFHX3 | 2.04e-05 | 376 | 171 | 13 | int:TLE3 |
| Interaction | HMCN2 interactions | 2.05e-05 | 7 | 171 | 3 | int:HMCN2 | |
| Interaction | ERG interactions | ARID3A ARID4B HIPK2 MLLT10 ARID1A PRPF40A EMSY ARID1B BRD2 QSER1 | 2.15e-05 | 223 | 171 | 10 | int:ERG |
| Interaction | RUNX1 interactions | ABCA2 DDX17 ARID3A CDKN2AIP HIPK2 ARID1A SF1 PHC1 CLIP4 KMT2A FIP1L1 HCFC1 | 2.19e-05 | 324 | 171 | 12 | int:RUNX1 |
| Interaction | HDAC1 interactions | RAF1 DDX17 ARID4B RBL2 POU2F1 INPP5F USP37 ARID1A ADNP RFX3 BIRC6 CASZ1 EMSY DENND4C SALL1 GLI3 MKI67 DOCK7 KMT2A ANKRD17 ZFHX3 HECTD1 HCFC1 ARHGAP21 | 2.25e-05 | 1108 | 171 | 24 | int:HDAC1 |
| Interaction | SOX2 interactions | DDX17 ARID3A ARID4B BAZ2B SIPA1L3 TRIOBP POU2F1 PROSER1 SIX4 ARID1A ADNP RFX3 CLOCK PHC2 PHC3 ARID1B SALL1 GLI3 NUFIP2 DOCK7 NAV2 KMT2A FIP1L1 ANKRD17 ZFHX3 QSER1 MARK2 ARHGAP21 | 2.49e-05 | 1422 | 171 | 28 | int:SOX2 |
| Interaction | KLF3 interactions | ARID3A ARID4B RFX7 ARID1A EMSY KAT2B ARID1B KMT2A ZFHX3 QSER1 | 2.60e-05 | 228 | 171 | 10 | int:KLF3 |
| Interaction | RAB11A interactions | RAF1 DENND4A PODXL ZDHHC5 MUC19 NBEA HEATR5A INPP5F BIRC6 ERBIN ATF2 DENND4C JPH1 KAT2B CCDC88A SYTL5 TOX3 MKI67 EXOC1 MARK2 | 2.63e-05 | 830 | 171 | 20 | int:RAB11A |
| Interaction | TOP1 interactions | RAF1 DDX17 ARID4B RBL2 RBM10 ARID1A ADNP PRPF40A BRD2 MTOR NUFIP2 MKI67 KMT2A FIP1L1 RPRD2 HECTD1 SPTY2D1 HCFC1 | 2.73e-05 | 696 | 171 | 18 | int:TOP1 |
| Interaction | NAA40 interactions | RAF1 DDX17 REPS1 DSG1 RBM10 CDKN2AIP NUP62 ADNP ERBIN PRPF40A SF1 EMSY PHC3 UBAP2L NUFIP2 MKI67 KMT2A ANKRD17 RPRD2 HCFC1 ARHGAP21 TP53BP1 | 2.90e-05 | 978 | 171 | 22 | int:NAA40 |
| Interaction | NF1 interactions | RAF1 DENND4A POU2F1 BIRC6 ATF2 DENND4C CTDP1 MKI67 MARK2 SH3RF3 | 3.75e-05 | 238 | 171 | 10 | int:NF1 |
| Interaction | TLX3 interactions | DENND4A ARID3A ARID4B POU2F1 PROSER1 ARID1A ARID1B SALL1 ZFHX3 QSER1 TP53BP1 | 4.03e-05 | 291 | 171 | 11 | int:TLX3 |
| Interaction | LYN interactions | PRUNE2 ARHGAP32 DSG1 ZDHHC5 GPRIN3 RICTOR ERBIN DENND4C ITPR1 JPH1 PHC3 CCDC88A BRD2 TOX3 DOCK7 KMT2A MARK2 ARHGAP21 | 4.25e-05 | 720 | 171 | 18 | int:LYN |
| Interaction | EYA4 interactions | RAF1 UBQLN2 CDKN2AIP PROSER1 SIX4 RFX7 SF1 CCDC88A QSER1 SPTY2D1 | 4.46e-05 | 243 | 171 | 10 | int:EYA4 |
| Interaction | TBR1 interactions | 5.08e-05 | 113 | 171 | 7 | int:TBR1 | |
| Interaction | S100A2 interactions | NES DENND4A ARID3A ARID4B RHBDF2 POU2F1 FAM117B SIX4 ATF2 CCDC88A RPRD2 CEP295 ARHGAP21 | 5.24e-05 | 412 | 171 | 13 | int:S100A2 |
| Interaction | BCOR interactions | RICTOR EMSY PHC1 PHC2 PHC3 SALL1 L3MBTL1 USP42 UBAP2L GLI3 QSER1 | 5.63e-05 | 302 | 171 | 11 | int:BCOR |
| Interaction | CRX interactions | ARID3A ARID4B POU2F1 PROSER1 ARID1A ARID1B SALL1 ZFHX3 QSER1 NPAS2 | 6.47e-05 | 254 | 171 | 10 | int:CRX |
| Interaction | CBX4 interactions | 6.58e-05 | 205 | 171 | 9 | int:CBX4 | |
| Interaction | CXADR interactions | ARHGAP32 UBQLN2 SIPA1L3 ZDHHC5 GPRIN3 RICTOR NBEA LRRC4C ERBIN JPH1 CCDC88A MARK2 | 7.69e-05 | 369 | 171 | 12 | int:CXADR |
| Interaction | FXR2 interactions | RAF1 DDX17 BAZ2B TRIOBP PHC2 L3MBTL1 UBAP2L NUFIP2 MKI67 ANKRD17 SPRTN HECTD1 TBX5 | 8.08e-05 | 430 | 171 | 13 | int:FXR2 |
| Interaction | BAG2 interactions | RAF1 AMBRA1 POU2F1 RICTOR ZFC3H1 ADNP ERBIN SF1 PHC1 PHC3 BRD2 DOCK7 RPRD2 GREB1 QSER1 ARHGAP21 | 8.30e-05 | 622 | 171 | 16 | int:BAG2 |
| Interaction | DIRAS3 interactions | ZDHHC5 GPRIN3 RICTOR NBEA CCDC88A CHEK2 MARK2 HERC1 HECTD1 ARHGAP21 | 8.37e-05 | 262 | 171 | 10 | int:DIRAS3 |
| Interaction | PAX7 interactions | 9.16e-05 | 124 | 171 | 7 | int:PAX7 | |
| Interaction | PHC3 interactions | 9.17e-05 | 86 | 171 | 6 | int:PHC3 | |
| Interaction | CCK interactions | 9.42e-05 | 11 | 171 | 3 | int:CCK | |
| Interaction | GSC interactions | 9.78e-05 | 87 | 171 | 6 | int:GSC | |
| Interaction | RHOB interactions | ARHGAP32 DOCK11 PODXL SIPA1L3 ZDHHC5 TRIOBP GPRIN3 RICTOR NBEA ERBIN JPH1 CCM2 CCDC88A CXCR4 STON2 DOCK7 MARK2 HERC1 ARHGAP21 | 9.81e-05 | 840 | 171 | 19 | int:RHOB |
| Interaction | AR interactions | RAF1 DDX17 RBM10 HIPK2 POU2F1 ARID1A ADNP ATF2 PRPF40A CASZ1 EMSY KAT2B ARID1B BRD2 UBAP2L GLI3 KMT2A ZFHX3 RPRD2 QSER1 HCFC1 | 1.06e-04 | 992 | 171 | 21 | int:AR |
| Interaction | RHOQ interactions | ARHGAP32 DOCK11 ZDHHC5 TRIOBP GPRIN3 RICTOR INPP5F ERBIN JPH1 CCDC88A MTOR MARK2 ARHGAP21 | 1.06e-04 | 442 | 171 | 13 | int:RHOQ |
| Interaction | RHOD interactions | ARHGAP32 PODXL ZDHHC5 TRIOBP RICTOR ERBIN DENND4C JPH1 CCM2 CCDC88A MTOR STON2 DOCK7 MARK2 ARHGAP21 | 1.13e-04 | 572 | 171 | 15 | int:RHOD |
| Interaction | PRPF40A interactions | RAF1 DDX17 UBQLN2 AMBRA1 PRPF40A SF1 NOMO1 NUFIP2 CHEK2 FIP1L1 ZFHX3 MARK2 HECTD1 | 1.16e-04 | 446 | 171 | 13 | int:PRPF40A |
| Interaction | XRCC6 interactions | RAF1 DDX17 UBQLN2 RBM10 CDKN2AIP POU2F1 RICTOR ADNP PRPF40A SF1 EMSY KAT2B CHEK2 MKI67 KMT2A ZFHX3 RPRD2 HECTD1 HCFC1 TP53BP1 | 1.23e-04 | 928 | 171 | 20 | int:XRCC6 |
| Interaction | LAMP1 interactions | RAF1 UBQLN2 ZDHHC5 TRIOBP GPRIN3 RICTOR NBEA INPP5F ERBIN DENND4C JPH1 CCM2 CCDC88A MTOR MARK2 ARHGAP21 | 1.24e-04 | 644 | 171 | 16 | int:LAMP1 |
| Interaction | HNF4A interactions | ARID3A ARID4B MUC19 ARID1A ADNP EMSY KAT2B ARID1B BRD2 QSER1 | 1.25e-04 | 275 | 171 | 10 | int:HNF4A |
| Interaction | TLX1 interactions | 1.27e-04 | 175 | 171 | 8 | int:TLX1 | |
| Interaction | COMMD3-BMI1 interactions | 1.32e-04 | 31 | 171 | 4 | int:COMMD3-BMI1 | |
| Interaction | CCNT1 interactions | RICTOR PRPF40A KAT2B NUFIP2 MKI67 KMT2A FIP1L1 ARHGAP21 TP53BP1 | 1.34e-04 | 225 | 171 | 9 | int:CCNT1 |
| Interaction | PHLPP1 interactions | NES RBM10 ARID1A SF1 DENND4C CCDC88A UBAP2L NUFIP2 ANKRD17 MARK2 HCFC1 | 1.34e-04 | 333 | 171 | 11 | int:PHLPP1 |
| Interaction | RHOC interactions | RAF1 ARHGAP32 PODXL ZDHHC5 RICTOR ERBIN ATF2 ITPR1 JPH1 CCDC88A CXCR4 STON2 KMT2A QSER1 MARK2 | 1.42e-04 | 584 | 171 | 15 | int:RHOC |
| Interaction | PDCD7 interactions | 1.43e-04 | 59 | 171 | 5 | int:PDCD7 | |
| Interaction | FHL2 interactions | CACNA1C ARID4B HIPK2 RFX3 EMSY PHC3 NUFIP2 TOX3 CHEK2 ANKRD17 QSER1 NPAS2 | 1.49e-04 | 396 | 171 | 12 | int:FHL2 |
| Interaction | GSK3A interactions | DENND4A SIPA1L3 RICTOR RFX7 ERBIN PRPF40A DENND4C CCDC88A GLI3 DOCK7 MARK2 HECTD1 ARHGAP21 | 1.72e-04 | 464 | 171 | 13 | int:GSK3A |
| Interaction | MEN1 interactions | DDX17 RBM10 ZFC3H1 ARID1A ADNP ERBIN ATF2 PRPF40A SF1 EMSY ARID1B NUFIP2 MKI67 KMT2A FIP1L1 ANKRD17 GREB1 NGLY1 QSER1 HCFC1 TP53BP1 | 1.75e-04 | 1029 | 171 | 21 | int:MEN1 |
| Interaction | SOX9 interactions | 1.78e-04 | 97 | 171 | 6 | int:SOX9 | |
| Interaction | CREBBP interactions | FOXO3 DDX17 RBL2 ANKS1B HIPK2 ARID1A CLOCK ATF2 KAT2B ARID1B GLI3 KMT2A MARK2 TP53BP1 NPAS2 | 1.86e-04 | 599 | 171 | 15 | int:CREBBP |
| Interaction | TFCP2L1 interactions | 2.00e-04 | 99 | 171 | 6 | int:TFCP2L1 | |
| Interaction | TOX4 interactions | 2.13e-04 | 142 | 171 | 7 | int:TOX4 | |
| Interaction | SMARCC2 interactions | RAF1 DDX17 ARID4B ARID1A ADNP PRPF40A ARID1B BRD2 KMT2A TP53BP1 TBX5 | 2.22e-04 | 353 | 171 | 11 | int:SMARCC2 |
| Interaction | MDC1 interactions | UBQLN2 RBM10 CDKN2AIP ARID1A EMSY PHC1 ARID1B BRD2 CHEK2 MKI67 RPRD2 TP53BP1 | 2.25e-04 | 414 | 171 | 12 | int:MDC1 |
| Interaction | NANOG interactions | RAF1 ARID3A MUC16 ARID1A EMSY PHC1 ARID1B SALL1 USP42 NUFIP2 QSER1 HCFC1 TP53BP1 | 2.44e-04 | 481 | 171 | 13 | int:NANOG |
| Interaction | RAC3 interactions | ARHGAP32 DOCK11 PODXL ZDHHC5 TRIOBP RICTOR FRYL ERBIN ITPR1 JPH1 CCDC88A CXCR4 STON2 MARK2 ARHGAP21 | 2.65e-04 | 619 | 171 | 15 | int:RAC3 |
| Interaction | KLF5 interactions | 2.67e-04 | 195 | 171 | 8 | int:KLF5 | |
| Interaction | RAC1 interactions | RAF1 ARHGAP32 DOCK11 PODXL SIPA1L3 ZDHHC5 TRIOBP RICTOR ERBIN DENND4C JPH1 CCM2 CCDC88A MTOR CXCR4 STON2 DOCK7 QSER1 MARK2 SH3RF3 ARHGAP21 | 2.72e-04 | 1063 | 171 | 21 | int:RAC1 |
| Interaction | CDC27 interactions | 2.85e-04 | 249 | 171 | 9 | int:CDC27 | |
| Interaction | SMARCB1 interactions | RAF1 ARID4B MLLT10 ARID1A KAT2B ARID1B BRD2 KMT2A HCFC1 MAPK8IP2 TP53BP1 | 2.89e-04 | 364 | 171 | 11 | int:SMARCB1 |
| Interaction | MED19 interactions | 2.89e-04 | 106 | 171 | 6 | int:MED19 | |
| Interaction | PAX6 interactions | ARID3A ARID4B HIPK2 POU2F1 SIX4 ARID1A ARID1B SALL1 ZFHX3 NGLY1 QSER1 | 3.03e-04 | 366 | 171 | 11 | int:PAX6 |
| Interaction | GATA2 interactions | 3.06e-04 | 199 | 171 | 8 | int:GATA2 | |
| Interaction | BTRC interactions | FOXO3 DDX17 UBQLN2 DSG1 HIPK2 USP37 ARID1A ERBIN BRD2 UBAP2L GLI3 RTL9 NUFIP2 MKI67 SNTG1 RPRD2 HCFC1 | 3.31e-04 | 775 | 171 | 17 | int:BTRC |
| Interaction | FOXP1 interactions | 3.49e-04 | 256 | 171 | 9 | int:FOXP1 | |
| Interaction | RAB2A interactions | RAF1 ZDHHC5 GPRIN3 RICTOR NBEA INPP5F ATF2 DENND4C JPH1 CCM2 CCDC88A MARK2 SPRTN ARHGAP21 | 3.53e-04 | 567 | 171 | 14 | int:RAB2A |
| Interaction | LRRC4C interactions | 3.53e-04 | 110 | 171 | 6 | int:LRRC4C | |
| Interaction | CTNNB1 interactions | FOXO3 RAF1 ARHGAP32 DDX17 USP17L2 SIPA1L3 FAM117B MLLT10 USP37 ADNP ERBIN ATF2 KAT2B CCDC88A PTPRA SALL1 MKI67 KMT2A HECTD1 ARHGAP21 | 3.67e-04 | 1009 | 171 | 20 | int:CTNNB1 |
| GeneFamily | CD molecules|Mucins | 4.28e-11 | 21 | 117 | 7 | 648 | |
| GeneFamily | AT-rich interaction domain containing | 2.15e-06 | 15 | 117 | 4 | 418 | |
| GeneFamily | Sterile alpha motif domain containing | 2.66e-04 | 88 | 117 | 5 | 760 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 4.10e-04 | 5 | 117 | 2 | 1333 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.13e-03 | 8 | 117 | 2 | 658 | |
| GeneFamily | Regulatory factor X family | 1.13e-03 | 8 | 117 | 2 | 1153 | |
| GeneFamily | ATAC complex | 3.09e-03 | 13 | 117 | 2 | 1058 | |
| GeneFamily | PDZ domain containing | 3.10e-03 | 152 | 117 | 5 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.96e-03 | 161 | 117 | 5 | 593 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.13e-03 | 15 | 117 | 2 | 529 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.30e-03 | 17 | 117 | 2 | 486 | |
| GeneFamily | Ubiquitin specific peptidases | 5.71e-03 | 56 | 117 | 3 | 366 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DENND4A DDX17 ARID4B DOCK11 RBL2 GPRIN3 RICTOR FRYL ZFC3H1 RFX7 ARID1A BIRC6 ERBIN ATF2 PRPF40A SF1 ITPR1 PHC3 KAT2B CCDC88A PTPRA USP42 SETD5 CXCR4 NUFIP2 KMT2A NGLY1 HERC1 | 4.84e-07 | 1492 | 172 | 28 | M40023 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | FOXO3 FLG ARID3A BAZ2B FRYL ZFC3H1 ADNP ATF2 PHC2 MKI67 TMCC1 NPAS2 | 7.52e-07 | 300 | 172 | 12 | M8702 |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | DDX17 DOCK11 RICTOR ZFC3H1 RFX7 ARID1A ARID1B CCDC88A TLR3 MKI67 | 8.75e-07 | 200 | 172 | 10 | M8088 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1C UBQLN2 SYN3 ANKS1B MUC19 POU2F1 GPRIN3 RICTOR LRRC4B NBEA FAM117B RFX7 GABBR2 CASZ1 JPH1 PIEZO2 CCDC88A TOX3 SNTG1 ZFHX3 HERC1 HYDIN MAPK8IP2 | 1.03e-06 | 1106 | 172 | 23 | M39071 |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 3.74e-06 | 184 | 172 | 9 | M19988 | |
| Coexpression | GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN | 7.07e-06 | 199 | 172 | 9 | M7129 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.62e-05 | 180 | 172 | 8 | M8239 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 5.34e-05 | 199 | 172 | 8 | M3070 | |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN | 5.53e-05 | 200 | 172 | 8 | M5806 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 5.53e-05 | 200 | 172 | 8 | M7495 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 5.53e-05 | 200 | 172 | 8 | M9041 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RICTOR FAM117B NUP58 RFX7 ATF2 SF1 NOMO1 PHC3 NOMO2 NUFIP2 HECTD1 NOMO3 | 7.41e-05 | 474 | 172 | 12 | M40991 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | WHRN NES ABCA2 ARID4B FZD3 SKIDA1 HIPK2 TRIOBP C11orf24 LRRC4B FRYL ZFC3H1 MLLT10 USP37 ARID1A RFX3 EMSY PHC1 PHC2 KAT2B CCDC88A SALL1 L3MBTL1 SETD5 MTOR TOX3 MKI67 DOCK7 FIP1L1 CEP295 ARHGAP21 TP53BP1 | 3.32e-08 | 1370 | 169 | 32 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ABCA2 ARID4B SWT1 FZD3 PODXL SKIDA1 HIPK2 LRRC4B ARID1A RFX3 PRPF40A EMSY PHC1 CCDC88A NETO2 SETD5 GLI3 TOX3 MKI67 DOCK7 FIP1L1 CEP295 GREB1 QSER1 HERC1 ULK2 TP53BP1 | 8.27e-08 | 1060 | 169 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NES ABCA2 ARID4B SWT1 FZD3 PODXL SKIDA1 ANKS1B HIPK2 LRRC4B ARID1A RFX3 PRPF40A EMSY PHC1 CCDC88A SALL1 NETO2 SETD5 CXCR4 GLI3 TOX3 MKI67 DOCK7 FIP1L1 CEP295 GREB1 QSER1 HERC1 ULK2 TP53BP1 | 2.32e-07 | 1414 | 169 | 31 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NES UBQLN2 ARID4B SWT1 FZD3 ANKS1B HIPK2 POU2F1 ARID1A ADNP PRPF40A EMSY PHC1 CCDC88A SALL1 L3MBTL1 KCNQ5 USP42 NETO2 SETD5 GLI3 TOX3 MKI67 DOCK7 FIP1L1 ZFHX3 CEP295 QSER1 ARHGAP21 TP53BP1 | 1.43e-06 | 1459 | 169 | 30 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | UBQLN2 ARID4B SWT1 FZD3 HIPK2 POU2F1 ARID1A ADNP PRPF40A EMSY PHC1 CCDC88A L3MBTL1 USP42 NETO2 SETD5 GLI3 TOX3 MKI67 DOCK7 FIP1L1 ZFHX3 CEP295 QSER1 ARHGAP21 TP53BP1 | 7.16e-06 | 1257 | 169 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | RAF1 ABCA2 UBQLN2 ARID3A FZD3 PODXL SIPA1L3 ZDHHC5 POU2F1 NUP62 NUP58 SIX4 RFX3 PHC1 SALL1 NOMO2 CXCR4 GLI3 TOX3 STON2 NAV2 ZFHX3 IQCJ-SCHIP1 GREB1 MARK2 | 8.05e-06 | 1187 | 169 | 25 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NES ABCA2 ARID4B SYN3 FZD3 STXBP5L POU2F1 FRYL CCDC88A SALL1 NETO2 CXCR4 GLI3 TOX3 STON2 MKI67 NAV2 CEP295 HECTD1 ARHGAP21 MAPK8IP2 | 4.07e-05 | 989 | 169 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | RAF1 REPS1 ARID4B DOCK11 STXBP5L ZDHHC5 POU2F1 ABCC9 C11orf24 ARID1A ADNP PRPF40A MSL2 GLI3 MKI67 ZFHX3 CEP295 QSER1 SPRTN MUC4 SH3RF3 | 4.07e-05 | 989 | 169 | 21 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | ABCA2 UBQLN2 FZD3 PODXL POU2F1 HEATR5A FSD1 MLLT10 PRAG1 RFX3 BIRC6 PRPF40A JPH1 SALL1 GLI3 TOX3 STON2 GREB1 SH3RF3 HCFC1 MAPK8IP2 | 4.38e-05 | 994 | 169 | 21 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ARID4B SWT1 PODXL HIPK2 SIX4 ARID1A ADNP RFX3 PRPF40A EMSY PHC1 PHC3 CCDC88A NETO2 SETD5 UBAP2L GLI3 TOX3 MKI67 DOCK7 ZFHX3 CEP295 GREB1 QSER1 | 5.67e-05 | 1252 | 169 | 24 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | DENND4A ARID4B DSG1 CDKN2AIP NBEA SIX4 USP37 RFX7 PRPF40A CCDC88A CLCA1 SALL1 TOX3 ZFHX3 RPRD2 MYOM2 SPTY2D1 TBX5 | 1.26e-04 | 836 | 169 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | REPS1 ARID4B STXBP5L POU2F1 ARID1A ADNP PRPF40A USP42 SETD5 UBAP2L GLI3 MKI67 CEP295 QSER1 HECTD1 | 1.58e-04 | 629 | 169 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | REPS1 ARID4B POU2F1 C11orf24 ADNP USP42 SETD5 UBAP2L CHEK2 MKI67 ANKRD17 ZFHX3 QSER1 HECTD1 | 1.75e-04 | 564 | 169 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | NES ABCA2 FZD3 PODXL POU2F1 PRAG1 SALL1 CXCR4 TOX3 STON2 NAV2 GREB1 MAPK8IP2 | 1.77e-04 | 496 | 169 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ARID4B STXBP5L POU2F1 CCDC88A NETO2 GLI3 MKI67 CEP295 HECTD1 ARHGAP21 | 2.02e-04 | 311 | 169 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | ABCA2 UBQLN2 SWT1 FZD3 PODXL TRIOBP POU2F1 C11orf24 PROSER1 FSD1 NUP62 MLLT10 ARID1A RFX3 PRPF40A EMSY SALL1 NETO2 SETD5 GLI3 TOX3 NAV2 ZNF888 GREB1 | 2.26e-04 | 1371 | 169 | 24 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.38e-04 | 259 | 169 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | UBQLN2 DOCK11 POU2F1 PROSER1 HEATR5A MLLT10 USP37 RFX7 RFX3 BIRC6 PRPF40A PHC1 GLI3 | 3.47e-04 | 532 | 169 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | WHRN ABCA2 REPS1 FZD3 BAZ2B OBSCN TRIOBP NBEA FAM117B INPP5F MLLT10 RFX7 CASZ1 PHC1 KAT2B ARID1B CCDC88A SALL1 CXCR4 GLI3 GREB1 TBX5 | 3.71e-04 | 1245 | 169 | 22 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | ARID4B HEATR5A USP37 BIRC6 ERBIN PRPF40A PHC3 CEP295 SPRTN SPTY2D1 | 3.62e-09 | 186 | 175 | 10 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | DENND4A ARID4B RICTOR BIRC6 ITPR1 ARID1B NUFIP2 KMT2A HERC1 TP53BP1 | 4.02e-09 | 188 | 175 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | POU2F1 HEATR5A FRYL USP37 ARID1A CLOCK BIRC6 DENND4C HECTD1 SPTY2D1 | 5.17e-09 | 193 | 175 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | ARID4B RICTOR ZFC3H1 PRAG1 RFX3 ERBIN ARID1B SETD5 TOX3 SNTG1 | 5.17e-09 | 193 | 175 | 10 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-08 | 174 | 175 | 9 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.07e-08 | 197 | 175 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 9.47e-08 | 198 | 175 | 9 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1C ARHGAP32 STXBP5L ANKS1B NBEA GABBR2 ITPR1 KCNQ5 SNTG1 | 9.47e-08 | 198 | 175 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 9.47e-08 | 198 | 175 | 9 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 9.47e-08 | 198 | 175 | 9 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-08 | 199 | 175 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.88e-08 | 199 | 175 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.03e-07 | 200 | 175 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.60e-07 | 192 | 175 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 198 | 175 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 198 | 175 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.26e-06 | 199 | 175 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-06 | 199 | 175 | 8 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.30e-06 | 200 | 175 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.82e-06 | 163 | 175 | 7 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.06e-06 | 179 | 175 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-06 | 184 | 175 | 7 | 840fac463665ed18752f402f7d1ef2e5052bdf74 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.39e-06 | 187 | 175 | 7 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.73e-06 | 188 | 175 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 189 | 175 | 7 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 190 | 175 | 7 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-05 | 190 | 175 | 7 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.12e-05 | 192 | 175 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 1.12e-05 | 192 | 175 | 7 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.19e-05 | 194 | 175 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.19e-05 | 194 | 175 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.19e-05 | 194 | 175 | 7 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 195 | 175 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 195 | 175 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 196 | 175 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-05 | 196 | 175 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-05 | 197 | 175 | 7 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 198 | 175 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 198 | 175 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-05 | 199 | 175 | 7 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 199 | 175 | 7 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Parenchyma_Control_(B.)|World / Sample group, Lineage and Cell type | 1.45e-05 | 200 | 175 | 7 | 220b6e5f936b3d08b031d6cabc5793213b98b8e2 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.86e-05 | 139 | 175 | 6 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.56e-05 | 156 | 175 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.56e-05 | 156 | 175 | 6 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.69e-05 | 157 | 175 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 159 | 175 | 6 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.25e-05 | 161 | 175 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.25e-05 | 161 | 175 | 6 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 4.25e-05 | 161 | 175 | 6 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.04e-05 | 166 | 175 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 5.94e-05 | 171 | 175 | 6 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.14e-05 | 172 | 175 | 6 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.34e-05 | 173 | 175 | 6 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.97e-05 | 176 | 175 | 6 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.19e-05 | 177 | 175 | 6 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.65e-05 | 179 | 175 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.89e-05 | 180 | 175 | 6 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.89e-05 | 180 | 175 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.38e-05 | 182 | 175 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.64e-05 | 183 | 175 | 6 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.64e-05 | 183 | 175 | 6 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.90e-05 | 184 | 175 | 6 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 8.90e-05 | 184 | 175 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.17e-05 | 185 | 175 | 6 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.17e-05 | 185 | 175 | 6 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.45e-05 | 186 | 175 | 6 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.45e-05 | 186 | 175 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.73e-05 | 187 | 175 | 6 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.73e-05 | 187 | 175 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 9.73e-05 | 187 | 175 | 6 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.73e-05 | 187 | 175 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.00e-04 | 188 | 175 | 6 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.03e-04 | 189 | 175 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.03e-04 | 189 | 175 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 189 | 175 | 6 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.06e-04 | 190 | 175 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 190 | 175 | 6 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 190 | 175 | 6 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.09e-04 | 191 | 175 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-04 | 191 | 175 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 191 | 175 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 192 | 175 | 6 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 192 | 175 | 6 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 192 | 175 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 192 | 175 | 6 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 192 | 175 | 6 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 192 | 175 | 6 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 192 | 175 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-04 | 193 | 175 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.16e-04 | 193 | 175 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 195 | 175 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.26e-04 | 196 | 175 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 196 | 175 | 6 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.26e-04 | 196 | 175 | 6 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 196 | 175 | 6 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 196 | 175 | 6 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| Computational | Neighborhood of MYST2 | 3.87e-06 | 172 | 99 | 10 | GCM_MYST2 | |
| Computational | Neighborhood of MAP4K4 | 2.81e-05 | 172 | 99 | 9 | GCM_MAP4K4 | |
| Computational | Neighborhood of SUFU | 7.33e-05 | 77 | 99 | 6 | GCM_SUFU | |
| Computational | Neighborhood of ZNF198 | 9.85e-05 | 117 | 99 | 7 | GCM_ZNF198 | |
| Computational | Neighborhood of PTPRD | 1.86e-04 | 58 | 99 | 5 | GCM_PTPRD | |
| Computational | Neighborhood of PTK2 | 3.72e-04 | 145 | 99 | 7 | GCM_PTK2 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 6.99e-07 | 172 | 170 | 10 | 7073_DN | |
| Drug | 2,4,4'-trichlorobiphenyl | FOXO3 PRUNE2 RAF1 DOCK11 BAZ2B STXBP5L ANKS1B TRIOBP GPRIN3 FRYL ADAM32 ARID1A CASZ1 ITPR1 JPH1 KCNQ5 SYTL5 TOX3 MKI67 DOCK7 SNTG1 NAV2 CEP295 GREB1 QSER1 SH3RF3 HCFC1 | 6.10e-06 | 1411 | 170 | 27 | ctd:C081766 |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.99e-06 | 178 | 170 | 9 | 1112_DN | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | FOXO3 PRUNE2 RAF1 DOCK11 BAZ2B STXBP5L ANKS1B TRIOBP GPRIN3 FRYL ADAM32 ARID1A CASZ1 ITPR1 JPH1 KCNQ5 SYTL5 TOX3 MKI67 DOCK7 SNTG1 NAV2 CEP295 GREB1 QSER1 SH3RF3 HCFC1 | 8.94e-06 | 1441 | 170 | 27 | ctd:C009828 |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | SIPA1L3 MLLT10 GABBR2 ARID1A SF1 CCDC88A KMT2A ULK2 MAPK8IP2 | 1.47e-05 | 192 | 170 | 9 | 1829_UP |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.66e-05 | 195 | 170 | 9 | 5313_DN | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.80e-05 | 197 | 170 | 9 | 5045_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.80e-05 | 197 | 170 | 9 | 3748_DN | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 1.87e-05 | 198 | 170 | 9 | 7095_DN | |
| Disease | smoking status measurement | FOXO3 CACNA1C ANKS1B LRRC4C MLLT10 GABBR2 RFX3 BIRC6 PHC2 SALL1 UBAP2L NUFIP2 CHEK2 SNTG1 NAV2 ZFHX3 CEP295 IQCJ-SCHIP1 QSER1 HERC1 | 1.53e-05 | 1160 | 172 | 20 | EFO_0006527 |
| Disease | Schizophrenia | CACNA1C ARHGAP32 SYN3 FZD3 AMBRA1 ADNP CLOCK CHRM4 PRODH2 PTPRA MTOR TLR3 NUFIP2 STON2 KMT2A MARK2 NPAS2 | 1.75e-05 | 883 | 172 | 17 | C0036341 |
| Disease | pulse pressure measurement | FOXO3 CDSN UBQLN2 PODXL TRIOBP ABCC9 NBEA HEATR5A FRYL CASZ1 DENND4C PHC2 ARID1B PIEZO2 KCNQ5 SNTG1 ZFHX3 IQCJ-SCHIP1 HCFC1 HYDIN TBX5 NPAS2 | 2.14e-05 | 1392 | 172 | 22 | EFO_0005763 |
| Disease | Adenoid Cystic Carcinoma | 2.72e-05 | 100 | 172 | 6 | C0010606 | |
| Disease | cortical thickness | FOXO3 FZD3 TRIOBP ABCC9 MLLT10 CLOCK ARID1B CCDC88A SETD5 GLI3 TOX3 DOCK7 NAV2 KMT2A IQCJ-SCHIP1 QSER1 ULK2 SH3RF3 ARHGAP21 | 2.90e-05 | 1113 | 172 | 19 | EFO_0004840 |
| Disease | cancer (implicated_via_orthology) | 2.98e-05 | 268 | 172 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 5.28e-05 | 69 | 172 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | FOXO3 FZD3 PODXL SKIDA1 ZDHHC5 FRYL MLLT10 DENND4C JPH1 CCM2 CCDC88A CXCR4 GLI3 TOX3 NAV2 IQCJ-SCHIP1 QSER1 SH3RF3 | 5.67e-05 | 1069 | 172 | 18 | EFO_0004346 |
| Disease | glycoprotein measurement | 7.24e-05 | 119 | 172 | 6 | EFO_0004555 | |
| Disease | cortical surface area measurement | FOXO3 REPS1 FZD3 BAZ2B PODXL SKIDA1 HIPK2 TRIOBP FAM117B FRYL PHC2 ARID1B CCDC88A GLI3 TOX3 NAV2 ZFHX3 QSER1 SH3RF3 ARHGAP21 | 1.19e-04 | 1345 | 172 | 20 | EFO_0010736 |
| Disease | ischemia (implicated_via_orthology) | 1.25e-04 | 17 | 172 | 3 | DOID:326 (implicated_via_orthology) | |
| Disease | Breast Neoplasms, Male | 2.01e-04 | 4 | 172 | 2 | C0242788 | |
| Disease | Carcinoma of Male Breast | 2.01e-04 | 4 | 172 | 2 | C0238033 | |
| Disease | Neurodevelopmental Disorders | 2.18e-04 | 93 | 172 | 5 | C1535926 | |
| Disease | cup-to-disc ratio measurement | 2.29e-04 | 430 | 172 | 10 | EFO_0006939 | |
| Disease | serum gamma-glutamyl transferase measurement | FOXO3 REPS1 DOCK11 SIPA1L3 TRIOBP ARID1A EMSY ITPR1 KAT2B SALL1 CHEK2 NAV2 KMT2A ARHGAP21 TP53BP1 | 3.16e-04 | 914 | 172 | 15 | EFO_0004532 |
| Disease | interstitial cystitis (is_marker_for) | 3.34e-04 | 5 | 172 | 2 | DOID:13949 (is_marker_for) | |
| Disease | mucositis (biomarker_via_orthology) | 3.34e-04 | 5 | 172 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 3.34e-04 | 5 | 172 | 2 | DOID:3030 (is_marker_for) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 3.34e-04 | 5 | 172 | 2 | C3281201 | |
| Disease | Hypertrophic Cardiomyopathy | 3.46e-04 | 57 | 172 | 4 | C0007194 | |
| Disease | Atrial Fibrillation | 3.63e-04 | 160 | 172 | 6 | C0004238 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.06e-04 | 301 | 172 | 8 | DOID:684 (is_marker_for) | |
| Disease | renal overload-type gout | 4.99e-04 | 6 | 172 | 2 | EFO_0021525 | |
| Disease | interleukin-6 measurement | 5.15e-04 | 112 | 172 | 5 | EFO_0004810 | |
| Disease | neuroticism measurement, cognitive function measurement | FOXO3 CACNA1C RBL2 ZDHHC5 ANKS1B MLLT10 ARID1A BIRC6 NAV2 ZFHX3 NPAS2 | 5.15e-04 | 566 | 172 | 11 | EFO_0007660, EFO_0008354 |
| Disease | aspartate aminotransferase measurement | WHRN CDKN2AIP OBSCN MUC19 GPRIN3 INPP5F MLLT10 PRAG1 BIRC6 ITPR1 MSL2 MTOR CHEK2 NPAS2 | 8.81e-04 | 904 | 172 | 14 | EFO_0004736 |
| Disease | hematocrit | CACNA1C DDX17 USP37 ITPR1 ARID1B SALL1 STRADA TOX3 ANKRD17 SPRTN LRRD1 ARHGAP21 HYDIN TP53BP1 TBX5 | 8.91e-04 | 1011 | 172 | 15 | EFO_0004348 |
| Disease | eosinophil cationic protein measurement | 9.24e-04 | 8 | 172 | 2 | EFO_0010913 | |
| Disease | Cornelia De Lange Syndrome | 9.24e-04 | 8 | 172 | 2 | C0270972 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 9.34e-04 | 74 | 172 | 4 | DOID:3748 (is_marker_for) | |
| Disease | uterine fibroid | 1.14e-03 | 199 | 172 | 6 | EFO_0000731 | |
| Disease | electrocardiography | RAF1 CACNA1C OBSCN ZDHHC5 LRRC4B ZFC3H1 CASZ1 NUFIP2 NAV2 TBX5 | 1.15e-03 | 530 | 172 | 10 | EFO_0004327 |
| Disease | ovarian neoplasm | 1.16e-03 | 134 | 172 | 5 | C0919267 | |
| Disease | temporal lobe epilepsy (implicated_via_orthology) | 1.18e-03 | 9 | 172 | 2 | DOID:3328 (implicated_via_orthology) | |
| Disease | longitudinal alcohol consumption measurement | 1.18e-03 | 9 | 172 | 2 | EFO_0007645 | |
| Disease | Malignant tumor of prostate | 1.18e-03 | 9 | 172 | 2 | cv:C0376358 | |
| Disease | bilirubin measurement | 1.20e-03 | 442 | 172 | 9 | EFO_0004570 | |
| Disease | Malignant neoplasm of ovary | 1.28e-03 | 137 | 172 | 5 | C1140680 | |
| Disease | Breast Carcinoma | 1.29e-03 | 538 | 172 | 10 | C0678222 | |
| Disease | testosterone measurement | RAF1 DENND4A UBQLN2 MLX ANKS1B ARID1A BIRC6 MSL2 KAT2B ARID1B KCNQ5 RTL9 NUFIP2 CHEK2 ZFHX3 GREB1 ARHGAP21 | 1.31e-03 | 1275 | 172 | 17 | EFO_0004908 |
| Disease | optic disc size measurement | 1.32e-03 | 205 | 172 | 6 | EFO_0004832 | |
| Disease | neuroblastoma (is_implicated_in) | 1.47e-03 | 10 | 172 | 2 | DOID:769 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 1.50e-03 | 142 | 172 | 5 | DOID:10534 (is_marker_for) | |
| Disease | brain measurement, neuroimaging measurement | FOXO3 CDKN2AIP SKIDA1 TRIOBP MLLT10 TOX3 NAV2 ZFHX3 IQCJ-SCHIP1 SH3RF3 | 1.52e-03 | 550 | 172 | 10 | EFO_0004346, EFO_0004464 |
| Disease | lung adenocarcinoma (is_marker_for) | 1.56e-03 | 85 | 172 | 4 | DOID:3910 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | RAF1 OBSCN POU2F1 SIX4 MAGEE1 ARID1A ATF2 EMSY ARID1B MTOR CXCR4 TOX3 CHEK2 MKI67 TP53BP1 | 1.62e-03 | 1074 | 172 | 15 | C0006142 |
| Disease | migraine disorder, Headache | 1.63e-03 | 86 | 172 | 4 | HP_0002315, MONDO_0005277 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.76e-03 | 41 | 172 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.76e-03 | 41 | 172 | 3 | C0858252 | |
| Disease | Nephrosclerosis | 1.79e-03 | 11 | 172 | 2 | C0027719 | |
| Disease | response to ondansetron, QT interval | 1.79e-03 | 11 | 172 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | guanosine diphosphate measurement | 1.79e-03 | 11 | 172 | 2 | EFO_0010494 | |
| Disease | Shortened QT interval | 1.79e-03 | 11 | 172 | 2 | C0151879 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.02e-03 | 152 | 172 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | waist-hip ratio, body mass index | 2.15e-03 | 12 | 172 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | extrapulmonary tuberculosis | 2.15e-03 | 12 | 172 | 2 | MONDO_0000368 | |
| Disease | Paroxysmal atrial fibrillation | 2.26e-03 | 156 | 172 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 2.26e-03 | 156 | 172 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.26e-03 | 156 | 172 | 5 | C2585653 | |
| Disease | brain connectivity measurement | 2.49e-03 | 400 | 172 | 8 | EFO_0005210 | |
| Disease | Coffin-Siris syndrome | 2.53e-03 | 13 | 172 | 2 | C0265338 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 2.53e-03 | 13 | 172 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | Neuroblastoma | 2.61e-03 | 47 | 172 | 3 | C0027819 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | FOXO3 NBEA LRRC4C BIRC6 PHC2 ARID1B UBAP2L NUFIP2 SNTG1 ZFHX3 IQCJ-SCHIP1 HERC1 | 2.68e-03 | 801 | 172 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | alpha fetoprotein measurement | 2.83e-03 | 100 | 172 | 4 | EFO_0010583 | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 2.94e-03 | 14 | 172 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | unipolar depression, anxiety | 2.94e-03 | 14 | 172 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | non-high density lipoprotein cholesterol measurement | REPS1 HEATR5A ARID1A DENND4C PHC1 NUFIP2 DOCK7 MARK2 MUC7 SPTY2D1 HYDIN | 3.21e-03 | 713 | 172 | 11 | EFO_0005689 |
| Disease | upper aerodigestive tract neoplasm | 3.30e-03 | 246 | 172 | 6 | EFO_0004284 | |
| Disease | hepatoblastoma (is_marker_for) | 3.37e-03 | 15 | 172 | 2 | DOID:687 (is_marker_for) | |
| Disease | liver volume | 3.37e-03 | 15 | 172 | 2 | EFO_0600048 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 3.37e-03 | 15 | 172 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | response to olanzapine | 3.37e-03 | 15 | 172 | 2 | GO_0097333 | |
| Disease | Prostatic Neoplasms | 3.43e-03 | 616 | 172 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.43e-03 | 616 | 172 | 10 | C0376358 | |
| Disease | amygdala volume change measurement | 3.84e-03 | 16 | 172 | 2 | EFO_0021490 | |
| Disease | osteosarcoma (is_implicated_in) | 3.84e-03 | 16 | 172 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | Seasonal Affective Disorder | 3.84e-03 | 16 | 172 | 2 | C0085159 | |
| Disease | Dermatitis | 3.84e-03 | 16 | 172 | 2 | C0011603 | |
| Disease | succinylcarnitine measurement | 3.84e-03 | 16 | 172 | 2 | EFO_0020020 | |
| Disease | triglycerides in medium VLDL measurement | 4.09e-03 | 55 | 172 | 3 | EFO_0022155 | |
| Disease | triglycerides in large VLDL measurement | 4.30e-03 | 56 | 172 | 3 | EFO_0022178 | |
| Disease | triglycerides in very large VLDL measurement | 4.30e-03 | 56 | 172 | 3 | EFO_0022325 | |
| Disease | Limb Deformities, Congenital | 4.34e-03 | 17 | 172 | 2 | C0206762 | |
| Disease | breast cancer (is_marker_for) | 4.68e-03 | 185 | 172 | 5 | DOID:1612 (is_marker_for) | |
| Disease | sleep apnea measurement | 4.81e-03 | 116 | 172 | 4 | EFO_0007817 | |
| Disease | Carcinoma, Granular Cell | 4.81e-03 | 116 | 172 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 4.81e-03 | 116 | 172 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 4.81e-03 | 116 | 172 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 4.81e-03 | 116 | 172 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 4.81e-03 | 116 | 172 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 4.81e-03 | 116 | 172 | 4 | C0001418 | |
| Disease | cognitive function measurement, self reported educational attainment | 4.96e-03 | 355 | 172 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | Polydactyly | 4.96e-03 | 117 | 172 | 4 | C0152427 | |
| Disease | prostate cancer (is_implicated_in) | 4.96e-03 | 117 | 172 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | triglycerides in VLDL measurement | 4.98e-03 | 59 | 172 | 3 | EFO_0022326 | |
| Disease | adverse effect, response to xenobiotic stimulus | 4.98e-03 | 59 | 172 | 3 | EFO_0009658, GO_0009410 | |
| Disease | triglycerides to total lipids in large HDL percentage | 5.22e-03 | 60 | 172 | 3 | EFO_0022330 | |
| Disease | total lipids in VLDL measurement | 5.22e-03 | 60 | 172 | 3 | EFO_0022314 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGNQSVRLVTSSSHN | 11 | P08173 | |
| SLSQSQASRVLGQSS | 411 | Q9H2P0 | |
| SSVTVTEGSRQQSSV | 1031 | Q4LE39 | |
| ASAQSSGASQSRVAS | 56 | Q9Y5B0 | |
| RSTIQRQSSVSSTAS | 1071 | Q96RT1 | |
| RQSSVSSTASVNLGD | 1076 | Q96RT1 | |
| LGAQQTSARSASLSS | 3731 | Q9NR09 | |
| ASLSSAATTGLTTQQ | 3741 | Q9NR09 | |
| TSAQHALTSVSRGSS | 311 | P61073 | |
| SSSRTLGSSSNTQNR | 651 | A6NCI8 | |
| ITNRSLSTVNSGTGV | 1721 | Q8IZF6 | |
| SPTSQQSSASLAAAT | 741 | Q86V15 | |
| SNTSSVIGINTSVLS | 176 | Q9UIF8 | |
| AIQHSSVSTSNGVSS | 451 | P15336 | |
| VLTASIASISGSSNS | 1231 | O60706 | |
| TSRSKSQDSTQTQSS | 771 | Q8TC27 | |
| ATNLNVGTSSSAASS | 1196 | Q8NFD5 | |
| ALSTTSSSTTNGNRA | 391 | Q9BSQ5 | |
| DSSRQSGTRHTQTSS | 2621 | P20930 | |
| ATSVTSQGTQTLALQ | 1096 | Q9C0C7 | |
| SNATTTTVTTTASNN | 2006 | O75179 | |
| TSGVSSSGQSVSSNQ | 201 | Q15517 | |
| TQSQGSSSQSQGISS | 26 | O96017 | |
| AGLNSSATSTANNSR | 466 | Q8N3C7 | |
| VSNSSVLASQSVGIT | 6 | Q9UF12 | |
| SSSIVRLTGTSNNSA | 961 | Q7Z401 | |
| SSEGSLSQRQRSTST | 246 | P04049 | |
| SNEGSRISAASVAST | 391 | P98175 | |
| STTVRVTNSNANAAS | 196 | P69849 | |
| TAESRTAQAAASGTT | 6 | Q2KHR3 | |
| SVVSRANSIGSTSAS | 91 | Q9UH92 | |
| SSQLMQSSGRSGSSL | 616 | Q99743 | |
| AGSLSSQQVTGTTLQ | 786 | Q08999 | |
| LATNLNVGTSSSAAS | 1076 | O14497 | |
| NGSQSVRTSSTINLS | 371 | Q7Z6G8 | |
| QVGTSVSSATNTSTR | 616 | P51610 | |
| GSKSQCQTRQTSATS | 1161 | P51610 | |
| TTNTATTSNAGSAQR | 1301 | P51610 | |
| TAASTLNTDASSVTG | 2116 | Q8WXI7 | |
| TVSSVNQGLQERSTS | 4301 | Q8WXI7 | |
| TATLEGQSTAASSRT | 51 | Q99102 | |
| GQSTAASSRTSNQDI | 56 | Q99102 | |
| ASSRTSNQDISASSQ | 61 | Q99102 | |
| SQSAGITASSVISQR | 261 | O00592 | |
| STTVRVTNSNANAAS | 196 | Q5JPE7 | |
| LQLSNSTSNSTGQRS | 366 | A8MTJ6 | |
| QFSETSTRTGTSQSL | 86 | A4D1F6 | |
| STRTGTSQSLSSLTG | 91 | A4D1F6 | |
| SLVTILNNSRSSSSA | 316 | P10071 | |
| NNASGATVATATTST | 156 | Q9H2X6 | |
| TSVTLAASEGRNTSR | 126 | Q9HCI5 | |
| SISIRTSSQTFQTGT | 566 | Q96IV0 | |
| TGQRSVQVSVTSSCS | 1206 | Q4ZG55 | |
| LTGTTDVSTSTTINN | 2126 | Q2M2H8 | |
| NASTSTNVANITATS | 2151 | Q2M2H8 | |
| SAGNITSNSISITTT | 2246 | Q2M2H8 | |
| TSNSISITTTSFGNS | 2251 | Q2M2H8 | |
| SASSRTSQLGIQTVI | 371 | Q92831 | |
| TTGRQSATSATSSKA | 266 | Q14643 | |
| NSSRGTNSTLAKITT | 616 | Q8N307 | |
| GASTATNSESRTTSN | 206 | Q5SSG8 | |
| LQKRGSATSSSNTSL | 481 | Q9BTV5 | |
| SNTSSLQITSIANAT | 146 | Q16836 | |
| QNSGCLSRSTSANIS | 671 | Q9NR82 | |
| AGSQSSLALTSTGQV | 621 | Q15751 | |
| VNSTSRSSSTESFGL | 581 | Q13387 | |
| TSLASLRSEQSNGSV | 161 | Q9HDC5 | |
| ARSSGISSQNSSTSD | 191 | Q9NXV6 | |
| ISSQNSSTSDGDRSV | 196 | Q9NXV6 | |
| AGILSSSSAASNRSR | 6 | Q9UL16 | |
| ASLDSGRTSTSNSNN | 1586 | Q3V6T2 | |
| SSLTSNAVSSVTAGA | 116 | Q9GZW8 | |
| RSVIVENSSGSTSAS | 196 | Q9Y468 | |
| TILSGSSNTEATNSI | 7646 | Q7Z5P9 | |
| TSSSISLGNNSAAIS | 1716 | O94915 | |
| SSQSQTSTASRKANS | 276 | Q6UN15 | |
| STTVRVTNSNANAAS | 196 | Q15155 | |
| SSVGSLQALSSSQRG | 1441 | P48681 | |
| SGSNSGNTATLTISR | 81 | P80748 | |
| SVGNTTASATLNVTA | 431 | Q9HCJ2 | |
| LSAVERLTQTSGQST | 2616 | P46013 | |
| LGSSNLTNAISSTVT | 116 | P37198 | |
| LTNAISSTVTSSQGT | 121 | P37198 | |
| SSSQSKAVASGQTQT | 996 | A7KAX9 | |
| VRNASTSTSVINVTG | 536 | Q9HCI7 | |
| RSQSFNTDTTTSGIS | 1216 | Q6R327 | |
| AQLISRSQASSSTSG | 136 | Q8NDX5 | |
| RSQASSSTSGSITQQ | 141 | Q8NDX5 | |
| TTNTGRQESTSSTNY | 501 | Q02413 | |
| NLSVTGTSDTTSNNT | 491 | P14859 | |
| EIQATGNTTTSTISR | 426 | Q7Z442 | |
| TNLINSSALSSAVTS | 481 | Q86XN7 | |
| ANASTSASNTVSGTV | 296 | O75400 | |
| SQASSSQVSSLRVGS | 7121 | Q5VST9 | |
| SQVSSLRVGSSQVGT | 7126 | Q5VST9 | |
| ATTISSRENVNTSSS | 136 | Q8TAX7 | |
| GQSLSNTLTTSLTST | 1631 | Q9ULT8 | |
| SSDQGTSNSTKRTSL | 1936 | Q4G0P3 | |
| ELQGNSTSISTLRTS | 1011 | Q86XA9 | |
| GSAGNATISTVSSTQ | 66 | Q13936 | |
| GENTRQSSTRSSVSQ | 1256 | Q5JSL3 | |
| VSSATSQSSGFSTNV | 1151 | Q96N67 | |
| SVSSASVSSQVRTQS | 131 | Q8IZ16 | |
| STNTEQDRVSRGTST | 556 | Q6P1L5 | |
| TVQRSQVSSISGGQS | 901 | Q5VZ89 | |
| TQSQASLQSASSVGS | 1366 | Q9BZC7 | |
| STNSVLSTSTNRSRN | 471 | Q7KZI7 | |
| TSTQGTSTHASSTQL | 551 | Q9NPG1 | |
| SVTSVNQASTSRLEG | 776 | O75899 | |
| TLCGEQTTTSTSNQT | 456 | A0A0U1RQI7 | |
| RNNVSSVSTTGTATD | 2221 | Q03164 | |
| LGQNTSTSSNLQRTV | 2256 | Q03164 | |
| STSSNLQRTVVTVGN | 2261 | Q03164 | |
| KLSVQSSGNRRSQSS | 476 | Q9NV70 | |
| VVITASQSSLVSNSS | 321 | Q7Z589 | |
| TSTGRSSQSSSQQFS | 666 | Q92841 | |
| TQNSQTRRSISSDTS | 726 | Q6ZVF9 | |
| RISSEQTGTSSSLSQ | 1196 | Q9C0D2 | |
| AASQSTSASPANTTV | 556 | Q5VT52 | |
| LGSRSQSLSSTDSSV | 901 | Q9Y2H2 | |
| TSSSPSQGTLRTSAN | 266 | Q9NSC2 | |
| SAGNTTASATLNVSA | 441 | Q9NT99 | |
| SGSNSGNTATLTISR | 81 | A0A075B6K5 | |
| TLNNLGGTTATTTTA | 151 | Q9BVL2 | |
| LTTVNSSDSDNGTTR | 76 | P18433 | |
| NGTTRTASTNSIGIT | 86 | P18433 | |
| TSTSYESQLGQNSSS | 1211 | A6NGG8 | |
| SGANITNATTAATTA | 1821 | P42345 | |
| SFTRGSTSTNAILTS | 576 | Q9H195 | |
| SRTNSNASTVSGRLS | 311 | O43524 | |
| GATSTLQTSVANSRS | 986 | Q8NET4 | |
| IAVSGTSLSSDQSRS | 311 | Q8TDW5 | |
| SLTNSLSTSDTSQRG | 541 | O14994 | |
| RSVANSGLSDSLTTS | 316 | Q7RTN6 | |
| IGSNVTRQRSHSGTS | 526 | Q96D71 | |
| VSNSRTSSTEAVAGS | 361 | Q8WUY3 | |
| SLTGSTQQSRSLGAQ | 776 | B4DYI2 | |
| SESRALSTSSNLGSQ | 276 | Q99593 | |
| GSTVTLQTSVASQAA | 11 | P48380 | |
| TSTQTIRQCSATGNT | 731 | P48380 | |
| SLTGSTQQSRSLGAQ | 926 | Q5VVP1 | |
| GNQATASTAASSATT | 496 | Q9NSN8 | |
| QTTTTTQAVQGRSIT | 1281 | Q8NFP9 | |
| GTTQTTGSNTVSVQL | 666 | Q8IVL1 | |
| DSSSGSSQVSVQSIR | 451 | Q1XH10 | |
| SVSQRRNTTTGASAA | 361 | O60292 | |
| SVAASQGNISVSSST | 511 | Q9UIU6 | |
| TGTLSSTSFPQNSRS | 1366 | Q9C0A6 | |
| GSQASSVKQSRTNLS | 441 | Q8NC67 | |
| SHGTSTTVSSARNTL | 531 | Q9P202 | |
| SSRASSQSNSTKVTP | 116 | B3KU38 | |
| STQQSRSLGAQSSRA | 786 | P0DKV0 | |
| RLGSNSALTTSNIAS | 776 | Q5T5J6 | |
| TISSKNIISRSSNGQ | 541 | Q68D10 | |
| RASSTQQETSRASST | 301 | Q9H2D6 | |
| RSQNSSISSTTGKSQ | 341 | Q8WXE9 | |
| SSRSLSGSTNTVASE | 586 | Q9Y2K9 | |
| AQQVAVSRLSASSSS | 766 | P25440 | |
| AVATTQANTLSGSSL | 621 | P55197 | |
| SAVNLTGTNGSNSIS | 506 | Q99856 | |
| SSQSINSQSVGSSLT | 481 | O15516 | |
| SSQTLTLTVTSRASN | 571 | A8K7I4 | |
| ATRAQTVATTANTSS | 211 | Q96F05 | |
| LTGSTQQSRSLGAQS | 931 | Q5VYP0 | |
| QASLVSNRQGSTSGS | 111 | Q8IXK0 | |
| STITNSAVQSTSNAS | 556 | Q9H9J4 | |
| SNSQLSTTSNTTFLG | 256 | O15455 | |
| LGSNSTVTASTRSSV | 766 | Q14157 | |
| STGETQTQSSSRLSQ | 386 | Q7Z417 | |
| LTGSTQQSRSLGAQS | 931 | Q5TZJ5 | |
| AQPTASQARSTISTA | 596 | Q8TEJ3 | |
| QTRNNLTTSKSGSCS | 1156 | Q6ZQQ2 | |
| TSTRNSSQKGSSVLS | 2121 | Q9H5I5 | |
| NSTLSAVSTTARGQT | 786 | Q7Z410 | |
| LAQTSSAVASSTDGS | 201 | O94876 | |
| ARVSSGSSSEVSSIN | 421 | Q2T9K0 | |
| ATIAASRQASSPNTS | 76 | P78364 | |
| TTTTQASINLATTSA | 96 | P78364 | |
| ATTSAAQLISRSQSV | 106 | P78364 | |
| TSTGNNQSTITLSVA | 516 | Q2KHR2 | |
| RSVQQTLASTNLTSS | 341 | O15405 | |
| GQRSLVQDSLSTNSS | 346 | Q12888 | |
| SQLSVSSQASTGSTQ | 921 | Q86YV5 | |
| KNSVSSSSQRRVSSS | 361 | Q9H040 | |
| SVENRTAQITSTGSL | 111 | Q9BS86 | |
| QRIEQNLTSTASSGT | 411 | Q8IYT8 | |
| SINNASSVSTSQRIS | 166 | P0CJ79 | |
| GQLQSIRSEGTTSTS | 441 | Q9C0B5 | |
| SGGTNLDRTNVSSQT | 281 | Q86T82 | |
| SNAAGTNTTSASTPR | 116 | Q9UHD9 | |
| KNGGSVSSVSSSRLQ | 6 | Q6PJF5 | |
| SGTLLSTSSQASLAR | 1546 | Q5T5U3 | |
| GSSSSSSSSQQQLRN | 71 | O60293 | |
| QQNTTTTTTSAGTGS | 526 | Q15637 | |
| STTRTDQESVNTGTL | 491 | Q6R6M4 | |
| QTLSRGTASTSSNSA | 541 | Q15911 | |
| QSTASKQSTASRQST | 201 | P52179 | |
| KSLSQRSSSQRASSQ | 46 | P54296 |